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1.0 EXECUTIVE SUMMARY 
 
Polychlorinated biphenyls (PCBs) are a group of man-made chemicals associated with a 
potential risk to human health and the environment. They were used in many building materials, 
particularly caulking, grout, expansion joint material and paint, from approximately 1950 to 1978. 
Both the U.S. Environmental Protection Agency (EPA) and the Agency for Toxic Substances 
and Disease Registry (ATSDR) have published extensive material evaluating human health 
impacts from exposure to PCBs. The apparent public health risks, including developmental 
effects in children, reproductive effects and long-term risks for cancer development, have driven 
consideration for actions, including further research into chronic health effects, mechanisms of 
contact, and assessing actual and potential exposures, both in public and commercial buildings, 
and in the workplace, where direct and incidental exposures may occur. 
 
Two major legislative and legal efforts in the U.S. bring us to the current consideration of PCBs 
as the next potential public health hazard abatement initiative. The Toxic Substances Control 
Act of 1976 (TSCA), implemented restrictions and prohibitions regarding the manufacture, use 
and disposal of PCBs in the U.S. The second involved legal action initiated by the New York 
Lawyers for the Public Interest (NYLPI) after a concerned parent read a 2004 publication on 
PCB investigations in Boston, Massachusetts schools and other buildings and subsequently 
investigated his own child’s school. Currently, the EPA and the City of New York are working 
together, under a Consent Agreement, to study and establish a policy for management of PCBs 
in K-12 schools. 
 
There is growing evidence that PCB exposures, in both vapor and particulate matter form, 
emanate from PCB-containing products in the building environment. Additionally, secondary 
sources of PCBs, including materials that have become contaminated due to absorption from 
direct contact with PCB sources, or through adsorption of PCBs in the air that have been 
emitted by primary sources, such as caulk or light ballasts, can contribute to the overall 
exposures. In most cases, the building owners and occupants are not even aware of the 
existence of these materials and their potential hazards. It is not clear what the risk from these 
PCB-containing building materials is when compared to other PCB exposures (e.g. diet), due to 
a lack of data on potential exposures from sources in the built environment. 
 
The purpose of this white paper is to 1) provide an overview of currently available information 
pertaining to PCBs in construction materials; 2) evaluate the exposure potential for building 
occupants, maintenance and construction personnel; and 3) identify gaps in the current 
knowledge base that would help occupational and environmental health professionals to better 
understand the risk to public health from PCBs in building materials. AIHA’s findings and 
recommendations will be updated as new information becomes available. 
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2.0 ACRONYMS AND DEFINITIONS 
 
ACGIH – American Conference of Governmental Industrial Hygienists. 
 
AIHA – American Industrial Hygiene Association. 
 
Aroclors – Trade name for various mixtures of chlorinated biphenyl congeners manufactured by 
Monsanto Chemical Company which were sold in the United States. (See PCBs) 
 
Aryl Hydrocarbon Receptor (AHR) – A cellular protein that is capable of binding to aryl 
hydrocarbons, leading to changes in gene expression within the cell nucleus which can result in 
abnormal cell function. 
 
ATSDR – Agency for Toxic Substances and Disease Registry. 
 
EPA – United States Environmental Protection Agency. 
 
DOD – United States Department of Defense. 
 
DOE – United States Department of Energy. 
 
HEPA – High Efficiency Particulate Air. An air filter which can remove at least 99.97% of 
airborne particles greater than 0.3 microns in size.  
 
IARC – International Agency for Research on Cancer. 
 
IRIS - Integrated Risk Information System. 
 
Liquid PCBs – A homogeneous flowable material containing PCBs and no more than 0.5 
percent by weight non-dissolved material. 
 
LOAEL – Lowest Observed Adverse Effect Level. The lowest concentration of a chemical in a 
study, or group of studies, that produces a statistically or biologically significant increase in 
frequency or severity of adverse effects between the exposed population and an appropriate 
control. 
 
NIOSH – National Institute for Occupational Safety and Health. 
 
NLPCBs – Non-liquid Polychlorinated Biphenyls. Materials containing PCBs that by visual 
inspection do not flow at room temperature (25oC or 77oF) or from which no liquid passes when 
a 100 gram or 100 milliliter representative sample is placed in a mesh number 60 +5 percent 
paint filter and allowed to drain at room temperature for 5 minutes. (From 40 CFR 761.3)  
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NOAEL – No Observed Adverse Effect Level. The highest concentration of a chemical in a 
study, or group of studies, at which there is no statistically or biologically significant increase in 
the frequency or severity of any adverse effects in the exposed population when compared to 
an appropriate control. 
 
Non-Legacy PCBs – Unintentionally produced PCBs that occur as trace contaminants in certain 
products, particularly inks and dyes. Under TSCA, PCB concentrations of up to 50 ppm are 
allowed in certain products as a result of manufacturing processes. 
 
OSHA – Occupational Safety and Health Administration. 
 
PCBs – Polychlorinated biphenyls. A group of compounds in which chlorine atoms replace the 
hydrogen atoms in biphenyl. PCBs were used in industry in electrical insulators and in the 
manufacture of plastics until 1979.  
 
PCB bulk product waste - Waste derived from manufactured products containing PCBs in a 
non-liquid state, at any concentration where the PCB concentration at the time of designation for 
disposal is greater than or equal to 50 parts per million. In 2012, the EPA proposed that building 
materials which have been “coated or serviced” with PCB-containing materials, such as caulk, 
mastics or sealants, can also be handled as PCB bulk product waste. 
 
PCB Congener – Any single, unique well-defined chemical compound in the PCB category. The 
name of a congener specifies the total number of chlorine substitutes and the position of each 
chlorine. There are 209 separate PCB congeners based on the number and position of the 
chlorine atoms on the biphenyl ring structure.  
 
PCB Homolog – A subcategory of PCB congeners having equal numbers of chlorine 
substituents. For example, tetrachlorobiphenyls are all PCB congeners with exactly 4 chlorine 
substituents that may be in any arrangement. There are 9 different homologs. 
 
PCB remediation waste – Waste that has become contaminated as a result of a spill, release or 
other unauthorized disposal of PCBs. This includes environmental media, such as soil, 
sediments, gravel, sewage and industrial sludge, rags and other debris generated as a result of 
any PCB spill cleanup, as well as building materials (e.g., concrete, masonry). 
 
PPE – Personal protective equipment. 
 
RfD – Reference dose. A numerical estimate of a daily oral exposure to the human population, 
including sensitive subgroups such as children, that is not likely to cause harmful effects during 
a lifetime. 
 
TLV® – Threshold Limit Value. 
 
TSCA – Toxic Substances Control Act. 
 
American Industrial Hygiene Association®  PCBs in the Built Environment White Paper 
 P a g e  | 4 
Unauthorized use – As per EPA TSCA regulations, any open applications (i.e., caulk) which 
contain PCBs greater than or equal to 50 parts per million by weight are considered an 
“unauthorized use” of non-liquid PCBs and requires removal of that material.  
 
3.0 INTRODUCTION 
 
Polychlorinated biphenyls (PCBs) are a group of man-made chemicals associated with risks to 
human health and the environment.[1,2] PCBs were manufactured in the United States from the 
late 1920s until 1979 for use in a variety of products including electrical equipment, hydraulic 
fluids, inks, lubricants, flame retardants, adhesives, surface coatings, insulating materials, 
pesticides, dyes, paints and plasticizers.[1,2,3,4,5] In the United States, TSCA promulgated a 
prohibition on the manufacture of PCBs, which became effective in 1979.[4,5]  
 
In the past, PCB exposures were thought to occur primarily in industrial and commercial settings 
where transformers, capacitors or other electrical equipment containing PCB fluids were 
located.[ 6 ] Growing evidence suggests that PCBs in construction materials may pose a 
previously unrecognized risk to building occupants, maintenance staff and those working in 
construction trades.[7] Building materials including caulking, adhesives, surface coatings, paint, 
ceiling tiles, window glazing, light ballasts and electrical wiring have been reported by various 
investigators inside and outside the United States to contain PCBs in the low parts per million 
(ppm) to percent (by weight or volume) quantities.[8]  
 
PCB exposures can occur in the built environment from direct contact, volatilization, 
deterioration, or disturbance of PCB-containing materials. Children may be at particular risk due 
to epidemiological evidence that PCBs are developmental toxins, and the fact that many of the 
school buildings currently in use were either built or renovated during the time period that PCBs 
were in use.[2,6,7,8,9,10]  
 
The potential public health implications from exposure to PCBs in construction materials are not 
well understood at this time. The evaluation of potential sources, pathways of human exposure 
and the collective health risk should assist the industrial hygienist in the selection of appropriate 
methods to control the exposure. Industrial hygienists are uniquely qualified to assist in the 
evaluation of this emerging issue and can apply the principles of industrial hygiene (i.e., 
anticipation, recognition, evaluation, control and confirmation) to PCBs in the built environment 
in order to reduce potential health risks for building occupants, maintenance staff and 
construction workers. 
 
The purpose of this document is to provide an overview of the available science and information 
pertaining to PCBs in construction materials, to evaluate the PCB exposure potentials for 
building occupants, maintenance and construction personnel, and to identify critical information 
gaps that need to be addressed. This document also provides the user with background 
information on PCB production, uses and toxicity.  
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4.0 BACKGROUND 
 
Polychlorinated biphenyls are a group of synthetic aromatic chemical compounds that have 
between one and ten chlorine atoms attached to a biphenyl ring structure.[1,2,6] There are 209 
separate PCB congeners, based on the number and position of the chlorine atoms on the 
biphenyl ring structure.[1,2,6,11]  Please refer to Appendix A for a table of the various PCB 
species by congener number. 
 
PCBs exist in a variety of physical states ranging from oily, viscous liquids to waxy solids that 
are colorless to light yellow.[2,11] PCB chemical and physical properties include a high dielectric 
constant, high solubility in hydrocarbons, very low solubility in water, thermal stability, low vapor 
pressure, resistance to acids and bases, and chemical inertness under most 
circumstances.[1,2,6,12] The physical properties, however, vary with degree of chlorination, 
such that those congeners with fewer chlorine atoms are both more water soluble and more 
volatile than those with more chlorine atoms. These properties make PCBs, particularly the 
more highly chlorinated congeners, extremely persistent in the environment once 
released.[1,2,12,13] This persistence of PCBs, coupled with their distribution through the food 
chain, has resulted in continuing human uptake and exposure. 
 
PCBs were manufactured in the United States from the late 1920s to approximately 1979.[1,2] 
PCB production was also reported in Austria, China, Czechoslovakia, France, Germany, Italy, 
Japan, the former Soviet Union, Spain and the United Kingdom.[1,2,6] Commercially produced 
PCB products in countries outside the U.S. include the trade names Clophen (Germany), 
Kanechlor and Sanotherm (Japan), Phenoclor (France) and Fenclor (Italy).[1,2,6]  
 
In the U.S., approximately 99 percent of all PCBs were manufactured by the Monsanto 
Chemical Company in Anniston, Alabama and Sauget, Illinois under the trade names Aroclor, 
Therminol, and Askarel.[1,2,6] Peak production of PCBs in the United States occurred in 1970 
with a reported production volume of 85 million pounds of Aroclors.[2,6] Reportedly, only 
approximately 130 of the 209 congeners were used in commercial production of PCBs.[1] 
Commercial PCB products were manufactured as a mixture of various PCB congeners, some of 
which could include 50 or more congeners.[1,2,6,11] PCBs were manufactured through 
progressive chlorination of biphenyls using anhydrous chlorine and iron filings or ferric chloride 
catalysts.[6] Common trace impurities include chlorinated naphthalenes and chlorinated 
dibenzofurans, which may play a role in the observed toxicity of PCBs.[1,2,6,11] From 1929 to 
1971, Monsanto produced eight separate Aroclors (1221, 1232, 1242, 1248, 1254, 1260, 1262 
and 1268).[2] After 1971, Monsanto voluntarily restricted production to Aroclor 1016, 1242, 1254 
and 1221.[2] 
 
Due to their unique chemical and physical properties, PCBs were used in a variety of 
commercial products. The commercial products are categorized into three basic types: closed 
applications, partially closed applications and open applications.[1,6]  
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Closed applications include use as dielectric fluids in: 
 transformers,  
 capacitors,  
 microwave ovens,  
 air conditioners,  
 fluid-cooled electric motors, and 
 electrical light ballasts and fluid-cooled electromagnets.[1,2,6] 
 
Partially closed applications include use in:  
 hydraulic fluids,  
 heat transfer fluids,  
 switches,  
 voltage regulators,  
 circuit breakers,  
 vacuum pumps, and  
 electrical cables.[1,2,6]  
 
Open applications include use in:  
 inks,  
 lubricants,  
 waxes,  
 flame retardants,  
 adhesives,  
 electrical and thermal insulating materials,  
 pesticides,  
 dyes,  
 paints and other surface coatings,  
 asphalt, and 
 caulks and sealants (e.g. as plasticizers).[1,2,6]  
 
At peak production in 1970, approximately 56 percent of PCBs were produced for use in closed 
applications, 30 percent in use in open applications, such as plasticizers, and 12 percent in use 
as hydraulic fluids and lubricants.[1,6] Aroclors manufactured by Monsanto were identified using 
a standardized four-digit numbering system, where the first two digits indicate the type of 
mixture and the last two digits indicate the approximate chlorine content, although there were 
exceptions to the naming convention (e.g. Aroclor 1016 which contains mono- through 
hexachlorinated homologs with an average chlorine content of 41 percent).[1,2,11] 
  
During their period of production, PCBs entered the environment from a number of different 
pathways, including accidental spills, leaks, fires, land disposal of PCB-containing products, and 
manufacturing processes and wastes.[1,2,13] PCBs are still entering the environment today 
through runoff from urban areas where PCB-containing buildings are prevalent, as well as 
improper land disposal of PCB-containing products and the resulting leachate from hazardous 
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waste sites where PCBs are not properly contained.[2,13,14] PCB contamination can be taken 
up by small organisms such as plankton and invertebrates in marine and fresh water 
environments.[1,2,13] The smaller organisms are then consumed by larger organisms, which 
can lead to bioaccumulation, where the highest concentrations of PCBs are found in animals at 
the top of the food chain, such as mammals, including humans.[1,2,13] While ingestion of 
animal fats is the major route of human exposure, exposures can also occur from breathing air 
contaminated with PCBs, drinking PCB-contaminated water or absorbing PCBs through the 
skin. Additionally, animal studies suggest that PCBs are more readily absorbed via inhalation 
than by ingestion.[15] 
 
Evidence of PCB toxicity in humans first appeared as early as the late 1930s.[16,17] It was not 
until the 1970s, however, that the U.S. Congress authorized the EPA to regulate PCBs due to 
concerns, including PCB bioaccumulation and long-term persistence in the environment.[2,4,13] 
The authority to regulate PCBs falls under TSCA, which implemented a number of restrictions 
and prohibitions regarding the manufacture, use and disposal of PCBs in the United 
States.[2,4,5,11,13] The goal of the TSCA regulation is the complete removal of PCBs as a 
health risk, although this goal is based on hazard identification and not necessarily applied risk. 
 
The TSCA regulations focused on liquid forms of PCBs (intact, predominantly in use as 
dielectric fluids) and the consequences of spilled liquids to surfaces, substrates and soils. Other 
downstream purchasers and consumers of manufactured PCBs were omitted from the 
regulations. As a result, materials which are identified to contain PCBs greater than 50 ppm, 
other than those allowances cited in the regulations (i.e., transformers), are considered an 
“unauthorized use” of PCBs and must be removed.  
 
In addition to the industrial and commercial sources of PCB pollution mentioned above, there is 
now growing evidence that PCBs are entering the environment through PCB-containing 
products in the built environment.[3,8,10,11,16,17,18,19,20] It has been estimated that over 154 
million pounds of PCBs were sold in the United States between 1958 and 1971 for use in 
various open-application products as listed above.[3] One study of buildings in Toronto, Canada 
found that 27% of the non-residential buildings surveyed contain detectable quantities of PCBs 
in sealants.[21] Published reports indicate that approximately 46% of all U.S. public and private 
schools currently in use were constructed between 1958 and 1971. Many of these schools may 
therefore have PCB-containing caulks, paints, adhesives and other open-application 
products.[3]  
 
Published studies indicate that airborne PCBs in concentrations exceeding EPA recommended 
public health guidelines can be present in buildings with PCB-containing components and 
construction materials.[3,18,19,20,22] The nature and extent of the release of PCBs from 
construction materials within the built environment is not well understood at this time. One 
limited study found that teachers working in buildings with PCBs had higher serum PCB levels 
when compared to a similar population that did not work in buildings with PCBs.[23] Given the 
apparent widespread use of PCBs in construction materials, it appears that PCBs in the built 
environment may be an underestimated public health risk for building occupants. Further 
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research is needed to help determine the role that construction materials may have in the 
exposure of building occupants to PCBs. 
 
For the purposes of this white paper, the term “toxicity” is the inherent property of PCBs to 
cause health consequences in humans; “exposure” is the sum of opportunities, through 
inhalation, skin permeation, ingestion and/or injection, to deliver PCBs where they can affect the 
human physiology; and “risk” is the probability of an adverse health effect and is dependent 
upon the exposure dose and toxicity of the agent(s) of concern.  
 
5.0 HEALTH EFFECTS 
 
PCB exposures have been associated, both directly and indirectly, with a number of acute and 
chronic health effects. Reported adverse health effects from PCB exposures include damage to 
the hepatic, endocrine, dermal/ocular, immunological, neurological, and reproductive systems, 
as well as cancer end points.[1,2,6,13] The reported health effects are based on studies of 
community exposures from ingestion of contaminated foodstuffs, occupational exposures during 
the manufacture of PCB mixtures (e.g. Aroclors) or PCB-containing components, and various 
animal studies.[2,24,25] Determination of the mechanisms for the associated health effects is 
complicated by a number of factors including the presence of other toxic contaminants from the 
manufacturing process, such as chlorinated dibenzofurans (CDFs) within PCB mixtures, and 
differences in the congener composition within commercially produced PCB mixtures compared 
to the congener profiles that are found in the soil, air, water, or food chain months or even years 
after release.[2,22,23] The presence of multiple PCB congeners and contaminants like CDFs, 
which have the potential to exert similar toxic effects, make determination of the specific agents 
responsible for a noted health effect difficult. [2,22,26] In addition, toxicity of PCB mixtures that 
are released into the environment may change due to effects of volatilization and chemical or 
biological transformation. [2,22,23,27] 
 
Highly chlorinated PCB congeners have traditionally been thought to present a greater risk of 
adverse health effects due to their persistence in the environment and ability to 
bioaccumulate.[2,22,23,25,28] Highly chlorinated PCB congeners tend to be less volatile, less 
water soluble, more likely to bind to sediment or soils and have higher bioaccumulation factors. 
[22,23] Conversely, less chlorinated congeners tend to be more volatile, more water soluble and 
more easily metabolized in animals.[22,23] However, while lower chlorinated congeners do not 
bioaccumulate to the degree that the higher chlorinated congeners do, this does not mean they 
do not cause adverse health effects. This is a particularly important consideration when 
exposure to lower chlorinated congeners is via inhalation, which occurs almost continuously 
when an individual in an indoor environment with PCB-containing materials present, but which is 
not reflected as clearly by measurement of blood concentrations due to the short half-lives of 
those congeners.  
 
Of the 209 PCB congeners, 12 have been categorized as “dioxin-like” and have been assigned 
toxic equivalency factors (TEFs) due to their ability to act upon the aryl hydrocarbon receptor 
(AHR) and cause toxic effects similar to those caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
American Industrial Hygiene Association®  PCBs in the Built Environment White Paper 
 P a g e  | 9 
[2,23,26, 29 ] Of the 12 dioxin-like PCB congeners, four are non-ortho substituted PCBs 
(congeners 77, 81, 126 and 169) and eight are mono-ortho substituted PCBs (congeners 105, 
114, 118, 123, 156, 157, 167 and 189).[23,26,27] The remaining 197 PCB congeners are 
sometimes referred to as “non-coplanar” or “non-dioxin like” congeners.[23] These non-dioxin-
like congeners are thought to exert toxic effects through multiple non-AHR mediated 
pathways.[23] 
 
5.1 Hepatic Effects 
 
Animal studies indicate that PCBs are capable of causing hepatic damage, including 
microsomal enzyme induction, liver enlargement, increased liver enzymes, fatty lesions, 
necrosis and tumors.[1,2,6,13] Studies of humans with high concentrations of PCBs in their 
blood have revealed the presence of abnormal liver indices such as cholesterol, liver enzymes 
and lipids.[2] PCBs are known to induce a great variety of gene expression, by both AHR and 
non-AHR-dependent mechanisms.[ 30 ] Human hepatotoxicity from PCBs, however, is not 
conclusive due to limitations including study designs, lack of controls, susceptibility differences 
among species and other confounding variables.[2] 
 
5.2 Endocrine Effects 
 
Evidence of direct endocrine effects from PCB exposures in humans is limited.[2] High 
exposures to PCBs in humans have been associated with goiter (enlargement of the thyroid 
gland).[2] Animal studies in rodents and non-human primates indicate that exposures to PCBs 
in utero and in early development (e.g. breast feeding) can deplete circulating levels of thyroid 
hormones and lead to hypothyroidism.[2] 
 
5.3 Dermal and Ocular Effects 
 
Dermal and ocular effects from PCB exposures in humans are well documented among 
occupational and community PCB exposure groups, the latter through accidental ingestion of 
PCB-contaminated food.[2,6,13] These effects include chloracne, pigmentation of the skin and 
nails, excessive eye discharge, swelling of the eyelids, distinctive hair follicles and edema of the 
hands and face.[2,6] 
 
5.4 Immunological Effects 
 
Immunological effects have been associated with PCB exposures in humans.[1,2] The strongest 
evidence of such effects is based on studies of communities that consumed PCB-contaminated 
food.[2] Increased susceptibility to infection was reported, although interpretation of the data 
was hampered due to the presence of multiple other persistent organic pollutants.[2] Animal 
studies indicate an association between high PCB exposures and morphological and functional 
changes in the immune system.[2] 
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5.5 Neurological Effects 
 
Neurological effects have been associated with PCB exposures in humans.[1,2] The primary 
evidence is based on epidemiological studies of communities that consume fish with high PCB 
concentrations.[2] Abnormal reflexes, memory, learning and IQ have been reported as 
neurologic outcomes associated with the PCB exposures. Human exposure studies have 
identified associations between behavioral effects and highly chlorinated congeners, while 
animal studies have shown an association between PCB exposures and central nervous system 
effects and have linked dioxin-like and non dioxin-like congeners to neurological effects.[2]  
 
5.6 Reproductive Effects 
 
Reproductive effects from PCB exposures have been reported, but human data are limited. 
[1,2,13] Animal studies in rodents and monkeys indicated that PCB exposures may be 
associated with menstrual changes.[2] Confounding variables in humans, however, make 
confirmation of similar menstrual disturbances, as well as effects on sperm morphology and 
production, difficult.[2] 
 
5.7 Developmental Effects 
 
Developmental effects have been associated with PCB exposures in animals and human 
studies.[2] Animal studies have linked PCB exposures in utero and during early development 
with hypothyroidism.[2] Thyroid deficiencies during fetal and neonatal development in humans 
can lead to auditory, motor and intellectual deficiencies.[2] A number of studies have associated 
developmental effects, including cognitive and motor skill deficiencies, delayed development, 
and behavioral problems, in children born to mothers who were exposed to PCBs and 
polychlorinated dibenzofurans (PCDFs) from eating contaminated food in Japan and 
Taiwan.[2, 31 , 32 , 33 , 34 , 35 ] Other studies have found associations with behavioral and 
intelligence deficits among children whose mothers were exposed to PCBs from eating 
contaminated food.[2,36,37,38,39,40,41,42] Prenatal PCB exposures have been associated 
with low birth weight, smaller head circumference and shorter gestational age in newborns, 
although the evidence is not conclusive. [2,34] 
 
5.8 Cancer 
 
Evidence of the association between PCBs and cancer in humans is supported by both 
retrospective epidemiological studies of workers exposed during manufacturing and repair of 
capacitors, and case-control studies of the general population, which looked at associations 
between adipose PCB concentrations and cancer.[1,2] These studies indicate an association 
between PCB exposures and cancers of the liver, biliary tract, intestines and melanoma.[2] In 
the late 1980s, the International Agency for Research on Cancer (IARC), the U.S. EPA and the 
National Toxicity Program (NTP) all classified PCBs as probable human carcinogens (IARC 
Group 2A) based on extensive evidence in animal studies.[1,2] The American Conference of 
Governmental Industrial Hygienists (ACGIH) did the same in 1996. Finally, the U.S. Department 
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of Health and Human Services (HHS) Agency for Toxic Substances and Disease Registry 
(ATSDR) addressed PCB carcinogenicity in 2000 and its addendum, issued in April 2011, 
added reference studies noting non-Hodgkins lymphoma and prostate cancer risks.[43]  
 
IARC recently revisited the issue of carcinogenicity of PCBs and has declared all PCBs to be 
Group 1, known human carcinogens, based on strong evidence for exposure increasing the risk 
of malignant melanoma, with less strong evidence for breast cancer and non-Hodgkins 
lymphoma.[44] Other cancers have also been reported to be increased in relation to PCB 
exposure, but overall evidence is limited.  
 
5.9 Diabetes, Cardiovascular Disease and Hypertension 
 
There is increasing evidence that the major chronic diseases of older age, including diabetes, 
cardiovascular disease and hypertension, but excluding cancer, are also associated with 
exposure to PCBs and other persistent organics, including dioxins and chlorinated 
pesticides.[45,46] Because these chemicals are all lipophilic and found in body fat, it is difficult 
to identify which chemical is responsible for the associations with these diseases. The exception 
is hypertension, which is strongly associated with serum PCBs levels but unrelated to 
concentrations of pesticides.[47]  
 
6.0 EXPOSURE EVALUATIONS 
 
6.1 Exposure Assessment 
 
The nature of the complete exposure profile from PCB-containing materials for building 
occupants and for the occupationally exposed is a complex one. Exposures to PCBs in the built 
environment can occur via inhalation of PCB vapors and contaminated particulates, as well as 
via ingestion and dermal pathways. The determination of the predominant pathways is key to 
controlling any potential exposures. Consideration should be given for modeling and then 
validating (through confirmatory sampling) the possible exposure pathways. Identification of the 
specific PCB congeners present should be considered, as the current literature suggests that 
lower molecular weight PCBs are more likely to be released before the higher molecular weight 
PCBs.  
 
6.2 Exposure Pathways 
 
6.2.1 Inhalation 
 
The inhalation pathway for exposure to PCBs includes both vapor and particulate exposures. 
Depending upon the nature of occupancy and activities occurring within the building, the 
inhalation pathway may be dominated by either of the physical forms, or the contributions may 
be equal. The release of PCBs into the built environment is largely dependent on the condition 
of the PCB-containing materials, presence (or absence) of impermeable coatings, air 
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temperature, ventilation dynamics and air flow rates. All of these factors must be taken into 
consideration when considering potential inhalation exposure pathways. 
 
6.2.1.1  Vapor Exposure Contribution 
 
Vapor exposure can occur from virtually any PCB-containing materials within a room or building. 
The predominant potential sources are failed fluorescent light fixture ballasts. These are, 
however, typically discrete, episodic exposures that are usually easily identified by failure of the 
light fixture. Of a more chronic nature is the vapor release of PCBs from caulking, as well as 
from other building materials that have absorbed PCBs over time and then subsequently re-
release them into the indoor environment. One study found a sum of 440 nanograms per cubic 
meter of air (ng/m3) of six PCB congeners in indoor air of a building constructed in 1969 of 
prefabricated concrete panels and sulfur-based caulk (Thiokols).[48] Other PCB sources within 
the building, however, could not be ruled out. Another study reported airborne PCB levels of 610 
micrograms per cubic meter of air (µg/m3) in inhabited apartments prior to testing various 
abatement methods.[49] 
 
During an initial assessment of airborne concentrations in school systems in Massachusetts, 
researchers detected Aroclor 1254 at concentrations ranging from 111 to 393 ng/m3.[ 50 ] 
Swedish researchers investigating biomarkers of exposure found that higher chlorinated PCB 
mixtures (Aroclor 1248, 1254 or 1260) were used in the manufacture of caulks, but that lower 
chlorinated PCB congeners (mainly PCBs 28, 52 and 66) were present in the air samples due to 
their higher volatility.[51]  
 
During testing of the efficacy of a variety of intervention methods at a school, researchers 
reported an initial mean indoor air total PCB concentration of 533 ng/m3.[3] The authors 
reported that by increasing outdoor air ventilation, encapsulating the caulk, and constructing a 
physical barrier over the encapsulated material, they were able to reduce indoor airborne PCB 
concentrations to a mean value of 76 ng/m3. 
 
6.2.1.2  Particulate Exposures Contribution 
 
Exposure to PCB-containing particulates is more likely to pose an inhalation risk to construction 
workers and remediation contractors than is exposure to PCB vapors, due to the generation of 
particulates during the dismantlement of structures and gross removal of PCB caulk and other 
materials. A number of studies have examined airborne exposures during these types of 
activities. 
 
Swedish researchers examined determining factors for controlling PCB exposures during the 
cleanup of PCB-containing sealants. A variety of methods and control sets were utilized, which 
resulted in worker breathing zone PCB concentrations ranging from 5.5 µg/m3 to 120 µg/m3.[49] 
Finnish researchers studied workers during a national abatement effort.[52] Both particulate and 
vapor phase samples for seven different PCB congeners (28, 52, 77, 101, 138, 153 and 180) 
were collected. No differentiation of the relative contributions of the various congeners, 
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however, was made. Reported airborne concentrations ranged from none detected to 3.1 
µg/m3.[52] 
 
From the variety of studies in the literature, it is clear that source identification and selection of 
PCB congeners for characterization is important when assessing the exposure opportunities to 
both public occupants and potential construction or maintenance forces. 
 
6.2.2 Ingestion 
 
Ingestion pathways are a consideration for both public and occupational exposures. When 
establishing the collective risk of PCBs in a structure, the behaviors of the occupants must be 
understood and taken into account. Small children are more likely to have ingestion pathway 
opportunities than older children, based simply on hand-to-mouth behavior. However, personal 
hygiene habits may also lead to ingestion paths for both older children in public exposures and 
workers in occupational exposures. Mapping of all occupants and their opportunities for coming 
into contact and possibly ingesting PCB-bearing particulates and settled dust is necessary for 
understanding this contribution to a total exposure determination.  
 
6.2.3 Dermal  
  
Skin notations exist in the ACGIH documentation for PCB 1242 based on reported fatty 
degeneration of the liver following dermal application to animals, and for PCB 1254 based on 
liver toxicity reported among animals treated dermally.[53] The designation of a “skin” notation 
indicates that there is the potential for significant contribution to the overall exposure by the 
cutaneous route, including mucous membranes and the eyes, through contact with vapors, 
liquids, and/or solids. Where dermal application studies have demonstrated that absorption 
could cause systemic effects following exposure, a skin notation would be considered.[54] 
 
6.2.4 Injection  
 
Injection exposures have not been identified in the literature as a potential pathway for PCB 
exposures. 
 
6.3 Biomonitoring 
 
Cumulative past exposure to PCBs can generally be determined through measurement of 
serum PCB levels. Adult age-related accumulations of non-dioxin-like PCBs have been 
observed in a number of studies.[55,56,57] Such studies can provide physicians and public 
health officials with reference values with which to determine whether or not individuals have 
been exposed to higher levels of PCBs than those found in the general population. Many PCBs 
can remain in the body for years after exposure, though some of the lower chlorinated PCB 
congeners have relatively short residence times.[ 58 ] Concentrations of individual PCB 
congeners in the body will vary with the exposure source(s) and differences in pharmacokinetics 
(i.e., congeners with longer half-lives will accumulate to higher levels within the body). Serum 
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concentrations of the di-ortho-substituted PCBs are typically higher than concentrations of the 
mono-ortho-substituted PCBs which, in turn, are greater than the coplanar PCBs.[57,58,59,60] 
Non-dioxin-like PCBs 138, 153 and 180 are the most frequently detected di-ortho-substituted 
PCBs reported in population studies and typically account for a substantial portion of total 
measured PCBs.[57,58,61,62]  
 
7.0 REGULATIONS 
 
7.1 Toxic Substances Control Act 
 
In the U.S., PCBs are regulated under TSCA, which was enacted by Congress in October 1976. 
The regulations are designed to protect public health and the environment from toxic chemicals, 
and those related to PCBs are codified in code of Federal Regulations, under 40 CFR 761, 
which includes regulations on the manufacture, processing, importation, distribution, use and 
disposal of PCBs. TSCA first established a ban on production of PCBs effective July 1979, with 
distribution in commerce banned after 1984. The regulation then established management 
policies for those materials that had already been produced prior to the ban. 
 
There is currently no requirement for a building owner or property manager to conduct air or 
bulk sampling to determine if PCBs are present in, or released from, building materials. The 
TSCA regulations do require that materials which may contain PCBs be characterized to ensure 
proper disposal if PCB wastes will be generated. This means that PCBs in the built environment 
may be identified during routine sampling of waste streams that will be generated during 
building renovation or demolition activities. 
 
If PCB-containing building materials are identified within a building or in the surrounding soils, 
specific actions are required based on the following criteria:  
 
1. Concentration of PCBs present in the identified building material; 
2. Classification of identified materials as either “PCB bulk product waste” or “PCB 
remediation waste”; 
3. Location of the PCB-containing materials; and 
4. Extent of any additional contamination that may have occurred to surrounding or 
adjacent building materials. 
 
Some of the key provisions of the TSCA rules that relate to PCBs in the built environment are 
summarized below.  
 
 Subpart A – General: 
o Defines the applicability of the rule, PCB concentration assumptions for use and 
definitions. 
o Defines “PCB bulk product waste” as waste derived from manufactured products 
containing PCBs in a non-liquid state, at any concentration in which the 
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concentration at the time of designation for disposal was greater than or equal to 
50 ppm PCBs. PCB bulk product waste includes, but is not limited to: 
 Non-liquid bulk waste or debris from the demolition of buildings and other 
man-made structures manufactured, coated, or serviced with PCBs. PCB 
bulk product waste does not include debris from the demolition of 
buildings or other man-made structures that is contaminated by spills 
from regulated PCBs that have not been disposed of, decontaminated, or 
otherwise cleaned up in accordance with subpart D of this part. 
 PCB-containing wastes from the shredding of automobiles, household 
appliances, or industrial appliances. 
 Plastics (such as plastic insulation from wire or cable; radio, television 
and computer casings; vehicle parts; or furniture laminates); preformed or 
molded rubber parts and components; applied dried paints, varnishes, 
waxes or other similar coatings or sealants; caulking; adhesives; paper; 
Galbestos; sound deadening or other types of insulation; and felt or fabric 
products such as gaskets. 
 Fluorescent light ballasts containing PCBs in the potting material. 
 
o Defines “PCB remediation waste” as waste containing PCBs as a result of a spill, 
release, or other unauthorized disposal, at the following concentrations: Materials 
disposed of prior to April 18, 1978, that are currently at concentrations ≥ 50 ppm 
PCBs, regardless of the concentration of the original spill; materials that are 
currently at any volume or concentration in which the original source was ≥ 500 
ppm PCBs beginning on April 18, 1978, or ≥ 50 ppm PCBs beginning on July 2, 
1979; and materials that are currently at any concentration if the PCBs are spilled 
or released from a source not authorized for use under this part. PCB 
remediation waste means soil, rags, and other debris generated as a result of 
any PCB spill cleanup, including, but not limited to: 
 Environmental media containing PCBs, such as soil and gravel; dredged 
materials, such as sediments, settled sediment fines, and aqueous 
decantate from sediment. 
 Sewage sludge containing < 50 ppm PCBs and not in use according to § 
761.20(a)(4); PCB sewage sludge; commercial or industrial sludge 
contaminated as the result of a spill of PCBs including sludge located in 
or removed from any pollution control device; or aqueous decantate from 
an industrial sludge. 
 Buildings and other man-made structures (such as concrete floors, wood 
floors, or walls contaminated from a leaking PCB or PCB-contaminated 
transformer), porous surfaces, and non-porous surfaces. 
 
o Defines “Totally Enclosed Manner” as any manner that will ensure no exposure 
of human beings or the environment to any concentration of PCBs. 
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 Subpart B – Manufacturing, Processing, Distribution in Commerce, and Use of PCBs 
and PCB Items: 
o Defines the prohibitions, exceptions, authorizations and storage requirements for 
the use and reuse of PCBs. 
o Bans the use of PCBs in anything but closed system applications. 
 
 Subpart C – Marking of PCBs and PCB Items 
o Defines the marking and labeling of PCB-containing items. 
 
 Subpart D – Storage and Disposal 
o Defines the storage and disposal requirements of PCBs 
o Defines cleanup levels for porous surfaces, non-porous surfaces in both high and 
low-occupancy areas. 
 
 Subpart G –  PCB Spill Cleanup Policy 
o Defines the requirements for cleanup of PCB spills 
 
 Subpart K – PCB Waste Disposal Records and Reports 
o Defines the requirements related to waste disposal activities including EPA 
identification numbers, notifications, waste manifests, retention of records and 
exception reporting. 
 
 Subpart N – Cleanup Site Characterization Sampling for PCB Remediation Waste  
o Defines the sampling of PCB bulk remediation waste, porous surfaces, non-
porous surfaces, and liquid PCB samples. 
 
 Subpart O – Sampling to Verify Completion of Self-Implementing Cleanup and On-Site 
Disposal of Bulk PCB Remediation Waste and Porous Surfaces.  
o Defines the sampling methods including sample size, sample collection 
procedures, compositing of samples, sample extraction and analysis and 
reporting and record keeping of PCB concentrations in samples. 
 
7.2 Department of Transportation 
 
The Department of Transportation, under 49 CFR Part 172, designated PCBs as hazardous 
materials and prescribes requirements for shipping papers, package marking, labeling, and 
transport vehicle placarding applicable to the shipment and transportation of PCBs. 
 
7.3 Comprehensive Environmental Response, Compensation and Liability Act 
 
PCBs are designated as hazardous substances under section 102(a) of the Comprehensive 
Environmental Response, Compensation and Liability Act of 1980 (CERCLA), as amended by 
the Superfund Amendments and Reauthorization Act (SARA) and section 311(b)(2)(A) of the 
Clean Water Act. The EPA has established a threshold reportable quantity of one pound for 
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PCB mixtures. If a PCB release exceeds this threshold quantity, then the EPA must be notified 
(40 CFR Part 302). 
 
7.4 Emergency Planning and Community Right to Know Act 
 
Under the Emergency Planning and Community Right to Know Act (EPCRA), which was an act 
amending CERCLA, PCB releases are included in the Toxic Release Inventory (TRI) database 
which is maintained by the EPA. The TRI database is publicly accessible and is intended to 
inform the general public and communities surrounding covered facilities about releases of toxic 
chemicals. 
 
7.5 Occupational Exposure Limits 
 
OSHA has established Permissible Exposure Limits (PELs) for two Aroclors that are expressed 
as eight-hour time-weighted average (TWA) exposure concentrations. The PELs, which are 
listed in 29 CFR 1910.1000, Table Z-1, are for chlorodiphenyl compounds containing 42 percent 
(Aroclor 1242) and 54 percent chlorine (Aroclor 1254). The PELs are 1.0 milligram per cubic 
meter of air (mg/m3) and 0.5 mg/m3, respectively, and both compounds have a “skin” notation, 
designating that significant exposure may occur through the dermal route.  
 
The National Institute for Occupational Safety and Health (NIOSH) has established a 10-hour 
Recommended Exposure Limit (REL) of 0.001 mg/m3 for both Aroclor 1242 and 1254, and lists 
both compounds as carcinogens. 
 
The 2013 ACGIH Threshold Limit Values (TLVs) for Aroclor 1242 and 1254 are identical to the 
OSHA PELs.[53,54]  
 
7.6 Department of Energy 
 
The Department of Energy (DOE) does not have any regulations that specifically address PCBs. 
However, the DOE, through the Worker Safety and Health Program found in 10 CFR Part 851, 
has codified the ACGIH TLVs for Aroclors 1242 and 1254. In addition, there is an expectation 
for a comprehensive exposure assessment program that would imply an effort at hazard 
identification. 
 
8.0 RISK ASSESSMENT 
8.1 Background 
 
There are four basic steps in the risk assessment process, whether focused on human health or 
toward environmental stressors. The steps include: 1) hazard identification, 2) dose-response 
assessment, 3) exposure assessment, and 4) risk characterization. These four steps are 
designed with the goal of formulating a detailed understanding of the potential severity and 
scope of a hazard – in this case, the risk of PCB exposure in the built environment. This 
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process is used by various U.S. government agencies, as well as some state, local and regional 
agencies, and other countries when performing risk assessments. The risk assessment for 
PCBs evaluates health impacts including both cancer and non-cancer end points. The hazard 
identification and exposure assessment components of the risk assessment process have been 
discussed in detail in section 6.1 of this document and are mentioned again briefly below to 
clarify the risk characterization.  
 
Exposed populations include building occupants (both adults and children), as well as 
construction workers renovating buildings and removing PCB-containing materials. 
Understanding the actual health risks will allow for cost-effective mitigation of PCB 
materials from indoor environments. In addition, the identification of target concentrations of 
PCBs in the indoor air will provide practitioners the values that can aid in the design and 
performance evaluation of various abatement activities.  
 
The current U.S. EPA-recommended levels for PCBs in indoor school air were set at varying 
concentrations, based on the children’s age, ranging from 70 ng/m3 for 1-3 year olds to 600 
ng/m3 for 15-19 year olds. The aim of these EPA levels was to keep children’s overall PCB 
intake to below the reference dose of 20 ng PCB/kg-day. An example of international guidelines 
for PCBs includes those established in Germany in 1995, which require the remediation of 
buildings with elevated indoor air concentrations. The action limit for remediation was set at 
3000 ng/m3, while tolerable PCB indoor air concentration was defined as 300 ng/m3. The aim of 
the German guidelines is to reduce airborne PCB concentrations in all living environments to 
below 300 ng/m3.[49]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Histogram of mean PCB congener pattern in indoor air in rooms with two different 
PCB sources [63] 
Figure 1 is an illustration of the concentrations of various congeners that were emitted into the 
indoor air from two different PCB-containing products, Thiokol rubber sealant and flame 
retardant coating on acoustic ceiling tiles. Clearly, the Thiokol sealant emitted greater levels of 
PCB 28 and 52 congeners than did the flame retardant material. Conversely, the flame 
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retardant material emitted higher levels of PCB 101, 138 and 153 congeners than did the 
Thiokol sealant. The figure above illustrates one of the challenges in conducting a risk 
assessment for PCBs, namely the uncertainty associated with an understanding of the source 
materials and the mixture of congeners within, and emitted by, those sources. 
 
Using the common four-step risk framework discussed above, the risks of exposure to PCBs 
can be examined. However, the numbers must be considered a reference point for decision-
making instead of a defining line between safe and unsafe. The exposures and dose-response 
relationships used to conduct any risk assessment are products of research publications and, 
while informative and thought provoking, the data are generally not appropriate for decision-
making. Understanding the uncertainties of a risk assessment will provide decision makers and 
stake holders the necessary information to take appropriate corrective actions.[64] 
 
8.2 Hazard Identification  
 
The U.S. EPA and ATSDR have published an extensive amount of material evaluating the 
human health impacts from exposure to PCBs. A useful summary can be found on the EPA’s 
Integrated Risk Information System (IRIS). Based on the weight of evidence in humans and 
experimental animals, the IARC upgraded PCBs from Group 2A, probably carcinogenic to 
humans, to Group 1, carcinogenic to humans in 2013.[44] More than 70 independent 
epidemiological studies with data for carcinogenicity of PCBs in humans were considered. 
Excess risks for melanoma were reported in several studies and a significant linear exposure-
response trend was noted in the largest study. The association between PCBs and melanoma 
was consistently noted in different North American and European industries.[44] The weight of 
the evidence is what will allow for the reduced uncertainty factors used to develop a Reference 
Dose (RfD) or slope factor. 
 
8.3 Dose Response  
 
The EPA’s IRIS provides a detailed assessment of the toxicity of PCBs. Table 1 is a summary of 
the information from the literature.  
 
Table 1. Carcinogenicity data, Oral Exposure 
 
Aroclor Type Dose (ppm) 
Human Equivalent 
(mg/kg/day) 
Tumor Incidence 
Aroclor 1260 
0 
25 
50 
100 
0 
0.35 
0.72 
1.52 
1/85 
10/49 
11/45 
24/50 
Aroclor 1254 
0 
25 
50 
100 
 
0 
0.35 
0.76 
1.59 
1/85 
19/45 
28/49 
28/49 
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Aroclor Type Dose (ppm) 
Human Equivalent 
(mg/kg/day) 
Tumor Incidence 
Aroclor 1242 
0 
50 
100 
 
0 
0.75 
1.53 
1/85 
11/49 
15/45 
Aroclor 1016 
0 
50 
100 
200 
 
0 
0.72 
1.43 
2.99 
1/85 
1/48 
7/45 
6/50 
Reference – EPA IRIS for PCBs and Brunner et al., 1997 [65] 
 
Slope factors are multiplied by lifetime average daily doses to estimate the cancer risk. PCB 
exposures are often characterized in terms of Aroclors, but this manner of profiling PCBs may 
not be precise as toxicity is linked more closely to specific congeners. Either central estimates 
or upper bounds can be used as appropriate measures of risk. In general, the central estimates 
describe an individual's risk, and the upper bounds provide a risk for a population. The EPA 
IRIS published central slope factor and upper bound slope factor for PCBs are 1.0 and 2.0 
(mg/kg)/day respectively for high risk persistence, while the slope factors for low risk and 
persistent exposure are 0.3 and 0.4 (mg/kg)/day, respectively. The above slope factors are 
generally used for ingestion of PCBs. The Unit Risk factor is often used for inhalation of 
evaporated congeners, where the low risk and persistent exposure slope factor (0.3 
(mg/kg)/day) is converted to a unit risk factor of 1 x 10-4 µg/m3. 
 
EPA has also published RfDs for non-carcinogenic endpoints. Oral RfDs for Aroclor 1254 of 20 
(ng/kg/day) and Aroclor 1016 of 70 (ng/kg) day have been published, where each RfD has an 
uncertainty factor of 300. The uncertainty factor of 300 was established to compensate for 
uncertainties when extrapolating data from a lowest observed adverse exposure level (LOAEL) 
to a no-observed adverse exposure level (NOAEL). It is important to understand, however, that 
PCB animal testing was conducted with the manufactured Aroclor material, and not with a 
mixture of PCB congeners that are more persistent in the environment. This again provides an 
uncertainty associated with the animal testing data and an understanding of human health 
impacts. Children’s exposure presents an additional uncertainty in that there may be greater-
than-proportional effects from less-than-lifetime exposure, especially for persistent mixtures and 
early-life exposures.  
 
8.4 Exposure Assessment  
 
As previously discussed in section 6.1, research into risk from airborne PCB exposures in 
buildings has been conducted in the U.S. and other countries by numerous scientists. Exposure 
data from a number of published studies is presented in Table 2.  
 
While the data are limited for both airborne exposures and serum levels for a specific study, a 
number of researchers have examined serum and airborne PCB concentrations at different 
times. Researchers studied the serum levels of six U.S. construction workers involved in 
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removing PCB-containing caulk. The workers were found to have statistically higher serum PCB 
levels than the reference population for specific congeners, namely PCBs 6, 16, 26, 32, 36, 41, 
70, 97 and 136.[66] The reported findings were similar to the results of studies previously done 
in both Finland and Sweden.[51,52] It should be noted, however, that the U.S. study quantified 
57 congeners, as compared to 24 congeners in the Finnish study and 19 congeners in the 
Swedish study. 
 
Table 2. Summary of select airborne exposures to PCBs from caulking/sealant  
 
Location PCB Source 
Total PCB Exposure 
(ng/m3) Reference for the 
Exposures 
Mean Min Max 
95 
CI 
School Window Caulk 533 350 780 
 
MacIntosh, 2012 [3] 
Office Building Window Caulk 1740 
 
4280 3740 Schettegen, 2012 [67] 
School Window Caulk 
 
2.4 30 
 
Sullivan, 2008 [68] 
University 
Office Building 
Caulk, Gaskets, 
Foamboard Insulation  
111 393 
 
Coughlan, 2002 [50] 
Worker - 
Construction 
Expansion Joint 
Removal with LEV* 
600 
   
Sundahl, 1999 [49]  
Office 
Buildings 
Joints and Window 45 
   
Hazarati, 2006 [69] 
Office 
Buildings 
Sealants & Flame 
Retardants 
715 715 2253 
 
Heinzow, 2004 [63] 
*LEV – local exhaust ventilation 
 
8.5 Risk Characterization  
 
In risk characterization, the hazard quotient and cancer risk for exposure to PCBs can be 
calculated. The Hazard Quotient (HQ) is a scaling factor and is not statistically based. If the HQ 
is greater than 1, then there may be an increased risk, while an HQ below 1.0 suggests no 
concerns for adverse health effects are present. The excess lifetime cancer risk is an 
incremental probability of the exposed persons developing cancer over a lifetime. Using the 
information from the ATSDR and IRIS for PCBs, along with published exposure levels, one can 
estimate the cancer risks and Hazard Quotients. However, as with all risk assessments, the 
calculated numbers must be viewed in the light of the multitude of uncertainties. As an example, 
if one considers only the variability in the exposures for building occupants, and keeps all the 
other variables constant, the cancer risks range over two orders of magnitude from 4/1000 to 
4.5/100,000. However, the non-cancer risk is significantly below unity for building occupants and 
workers from the published exposure data, although there are reasons to question whether the 
non-cancer risks have been adequately identified.  
 
Hazard Quotient (HQ) = Chronic Daily Intake/RfD 
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Cancer Risk = Chronic Daily Intake x Slope factor or Unit Risk Factor 
 
Of greater interest for those concerned with the health of workers, building occupants and 
school children is the paucity of data with respect to the exposure to specific congeners. Several 
different studies have shown increased serum PCB levels among construction workers when 
compared to control groups. These studies examined the ratio of light to heavy congeners to 
understand the source of PCB exposure.[51,52,66] In a comparison of congener profiles for 
PCB 6 to 74, one study found that the control group values for lighter congeners did not exceed 
those of the construction workers.[46] Researchers in a 2006 study proposed that a set of 
marker PCB congeners – specifically PCBs 44, 56, 60, 66, 70, 110, 153 and 180 - be used to 
track occupational exposures. Their general conclusion was that the traditional set of serum 
markers used to measure PCB exposures (PCBs 28, 52, 101, 101, 118, 138, 153 and 180) 
were not well suited for identifying occupational exposures.[51] While there are relatively few 
studies linking PCB congener airborne concentrations to PCB serum congener levels for the 
same set of workers, the limited results have observed a relationship between occupational 
exposure and serum levels. However, the limited number of studies and the varying number of 
congeners evaluated by each of those studies does result in a significant uncertainty within the 
risk assessment process. 
 
While only limited congener-specific airborne data are available, protective measures have been 
shown to reduce worker exposures. Two recent studies identified a series of control measures 
to protect workers and building occupants.[3,70] Reductions in airborne levels of PCBs and 
reduced PCB serum levels over time were observed even though individuals continued working 
as PCB abatement workers.  
 
9.0 IDENTIFICATION AND EVALUATION OF PCBs IN BUILDINGS 
 
9.1 Inspection and Material Testing 
 
As noted above, buildings constructed, renovated and/or repaired between 1950 and 1978 are 
likely to contain a variety of building materials containing PCBs.[5] To assess if building 
materials contain PCBs, bulk samples must be collected and analyzed. Analysis should be 
done by an environmental laboratory that is certified to analyze such samples. Additionally, 
PCBs from caulking, mastics, paint and other coatings are often absorbed into the porous 
building materials on which they were applied.[71] As a result, significant levels of PCBs can 
migrate into adjacent materials and be present several inches deep into adjacent wood, 
concrete, cinder block, brick or masonry. Additionally, PCBs from exterior caulks, sealants and 
paints can migrate into and contaminate surrounding soil as a result of natural weathering. 
Accordingly, sampling of any exposed soil around the perimeter of the building may also be 
warranted.  
 
Assessment and sampling must be done correctly and the building occupants must be protected 
from excessive exposure to PCBs during those activities. For this reason, inspection and 
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sample collection are usually done off hours or on weekends when building occupants are not 
present. Some materials, like caulking, may also contain other regulated contaminants, such as 
asbestos or lead, in addition to PCBs. Therefore, assessment protocols and methodologies 
similar to those used for these materials can be used as a template. While there are no 
nationally recognized PCB inspector certifications, facility owners may want to consider using 
inspectors accredited under the EPA Asbestos Hazard Emergency Response Act (AHERA) or 
Lead-Based Paint Renovation, Repair and Painting (RRP) certification programs. All individuals 
should also have PCB awareness training.  
Training for individuals who will be collecting samples should include the following: 
 Hazard Communication training for PCBs that, at a minimum, meets the requirements of 
29 CFR 1910.1200; 
 The importance of safe work practices to minimize the release of, and exposure to, 
potential PCB materials during sample collection; 
 Information on other hazardous materials (e.g. lead, asbestos) that may also be present; 
 Materials that should be suspected to contain PCBs, including surrounding materials 
that PCBs may have migrated to over time; 
 Sample collection methodology, including information on collecting sufficient quantity for 
analysis, proper storage containers, utilizing sampling techniques that minimize release 
of PCBs into the environment; 
 Proper use of PPE per the manufacturers’ user instructions; and,  
 Instructions that eating, drinking and smoking are prohibited during sample collection 
and not allowed until mandatory hand and face washing has been completed 
 
Additional information on sampling building materials for PCBs is available on the U.S. EPA 
website. 
 
As previously mentioned, TSCA considers materials containing greater than 50 ppm PCBs to be 
an unauthorized use of PCBs and such materials must be removed.[4] There is no requirement 
under current federal regulations, however, for building owners to perform sampling for PCBs in 
building materials. Currently, the EPA recommends conducting preliminary air testing in school 
buildings to determine airborne PCB levels prior to deciding whether or not to inspect for PCB-
containing building materials, although again there is no legal obligation to do so. 
 
Prior to performing an inspection, construction records (if available) should be reviewed to help 
identify suspect materials and possible PCB-containing equipment (e.g., transformers, light 
ballasts and heat transfer systems). Sampling of caulking and other suspect materials should 
include a visual assessment for different ages and types of applications, homogeneity of 
materials, applicability and use of the products, the condition of the materials and other field 
observations. Additionally, the potential for human exposure to materials (i.e., accessibility, 
frequency and duration of contact) should be determined and noted.  
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When performing bulk material or soil sampling, disposable sampling tools should be utilized 
and discarded after each sample in order to avoid cross contamination. Alternatively, stainless 
steel sampling instruments may be used but must be properly decontaminated between 
samples. Sampling of adjacent porous building materials, such as concrete or masonry, is more 
labor-intensive and requires core sampling in order to identify how deeply the PCBs have been 
absorbed. Core sampling involves drilling into the substrate material and collecting the dust or 
debris that is generated. Proper decontamination of the drill bits and equipment between 
samples is essential.  
 
Analysis of bulk material samples for PCBs is typically performed via EPA Method 8082A using 
gas chromatography (GC). The method can be used to determine concentrations of either 
Aroclors or as certain individual congeners (the method can only detect 19 of the 209 PCB 
congeners). Alternately, a high-resolution gas chromatography/high resolution mass 
spectrometry (GC/MS) method, such as EPA Method 1668B, can be used to quantify individual 
PCB congeners, although such methods can be quite costly to perform. In addition to PCBs, the 
sampled materials should also be assessed for other possible contaminants (i.e., asbestos and 
lead).  
 
Surface wipe sampling may also be performed to assess visual staining of surfaces from liquid 
PCB sources and dust accumulation from deteriorated building materials in accordance with 
EPA Method SW-846-8082 as described in 40 CFR 761.123 and 761.130. 
 
Personal protective equipment (PPE) used during sample collection will depend on the material 
being sampled and its condition. Intact items like light fixture ballasts, or soft, pliable caulking, 
will likely not require any PPE other than chemical protective gloves, such as nitrile, to minimize 
skin contact and American National Standards Institute (ANSI) Z87.1-compliant eye protection. 
The glove manufacturer should be consulted for suitability of the glove for incidental contact with 
PCBs. If the suspect PCB-containing material is friable (e.g. dry, brittle caulk), will be 
mechanically disturbed (e.g. concrete drilling) or is leaking (e.g. ballasts, transformers), 
respiratory protection may also be required. Depending on the condition of the material and the 
extent of sampling required, task-specific PPE may be required. 
 
10.0 AIR MONITORING 
 
For determining the presence of PCBs in indoor air, the EPA currently has two approved 
methods: Compendium of Methods for the Determination of Toxic Organic Compounds in 
Ambient Air – Compendium Method TO-4A (high air volume); and Compendium Method TO-
10A (low air volume).[72,73] Both methods utilize sorbent cartridges containing pre-cleaned 
open-cell polyurethane foam (PUF) as the sampling media, and analysis by GC coupled with an 
electron capture detector (ECD), nitrogen-phosphorus detector (NPD), flame photometric 
detector (FPD), Hall electrolytic conductivity detector (HECD) or a mass spectrometer (MS).  
 
Personal sampling for Aroclors 1242 and 1254 can be accomplished utilizing the National 
Institute for Occupational Safety and Health (NIOSH) 5503 method. Samples are collected 
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utilizing a sampling train consisting of a 13 mm glass fiber filter followed by a solid sorbent tube 
containing deactivated Florisil. Analysis of the samples is performed using GC/ECD.[ 74 ] 
Analysis should be done by a certified laboratory, such as those accredited under the AIHA 
Industrial Hygiene Laboratory Accreditation Program.[75]  
 
11.0 REMEDIATION  
 
The EPA published the findings of a literature review of remediation methods for PCBs and 
PCB-containing building materials in January 2012.[8] PCB remediation is broadly defined as 
removing PCB sources from buildings, removing PCBs from building materials, or limiting their 
migration or release from sources in buildings. PCB remediation methods are generally 
classified as either abatement or mitigation. The purpose of abatement is to remove or reduce 
the amount of PCBs in building materials through physical removal or chemical treatment of 
source materials. Mitigation is intended to control human exposures to PCBs by limiting their 
release from building materials and accumulation in indoor air and surface dust. Mitigation is 
often considered a complement to abatement operations. 
 
11.1 Abatement 
 
Abatement methods include the physical removal of primary and secondary PCB sources by 
various manual or mechanical means and chemical treatment or decontamination techniques to 
reduce PCB concentrations in PCB sources. Abatement is considered a permanent solution to 
PCB-containing building materials through source removal or reduction of PCB concentrations 
in those materials to below the clearance criteria for residual PCBs as defined in 40 CFR Part 
761. 
 
Physical removal is the method of choice for primary source materials such as caulk, glazing, 
paint, ceiling tiles and other bulk materials. Hand tools are readily available for removal of 
various building materials, including utility knives, putty knives, scrapers, ripping chisels and 
bush hammers. Manual methods generally generate less dust, waste, noise, vibration and odor 
than do mechanical and chemical removal methods. Caulk found on building exteriors is 
generally hard and brittle, whereas caulk found in building interiors is often soft and flexible, 
making manual removal somewhat less challenging. Mechanical methods are typically used for 
other PCB sources such as surfacing materials (e.g., paints, adhesives, etc.). Abrasive blasting 
methods include sand, shot, bead, hydro and carbon dioxide (dry ice) blasting. Mechanical 
tools, including various hand-held or large-scale grinding, scraping and cutting equipment (e.g., 
scabblers), are generally employed for removal of secondary sources such as brick and 
concrete. HEPA-filtered vacuum attachments should be used to contain the dust generated 
during mechanical removal activities. Tools and removal methods that produce heat above 212 
degrees Fahrenheit may generate gases that contain PCBs and should be avoided.[76] 
 
Chemical treatments of PCB-containing building materials include chemical degradation or 
extraction methods intended to reduce the PCB concentration of the source materials. 
Commercially available chemical degradation products are typically applied to sources as a 
American Industrial Hygiene Association®  PCBs in the Built Environment White Paper 
 P a g e  | 26 
slurry or paste, covered with an overlying material and left in place for days to weeks for the 
chemical reaction to produce less hazardous substances. One dechlorination product has been 
reported to reduce PCB concentrations on various surfaces, including steel ship bulkheads, 
railroad ballast, soils and bulk oils, by 90 to 99 percent.[8] Its effectiveness on caulks and 
painted surfaces is being studied but findings have not yet been made available. Another 
chemical degradation method, known as the Activated Metal Treatment System, has been used 
on caulk, concrete and painted surfaces and is reportedly more cost-effective on porous 
materials such as concrete than building demolition and disposal.[8] Waste materials to be 
managed and disposed of include both the spent product and the degradation products. 
 
Chemical extraction and cleaning methods are typically employed as a precursor step to source 
encapsulation or as a follow-up step to bulk removal.[8] One commercially available product for 
PCB extraction is a water-based solvent with emulsifiers, which has been used on concrete with 
varying results. Odor complaints and significant waste streams are reported concerns with the 
use of this product.[8] Another chemical extraction method used on brick and concrete is the 
EPA-prescribed double wash and rinse procedure (under 40 CFR 761 Subpart S) with detergent 
and solvent washes and potable water and solvent rinses. There are several commercially 
available degreaser solvents that can be used. Other chemical cleaning methods for removal of 
residual PCBs from nonporous surfaces employ solvents such as mineral spirits, kerosene, 
diesel and terpene hydrocarbons, in addition to commercially available cleaning agents such as 
trisodium phosphate. The EPA study, however, noted that “bleed-back” of oils and PCBs in 
concrete occurred within days of chemical cleaning efforts with all solvents used. This finding 
was attributed to the capillary rise of the oil in which the PCBs are dissolved.[8] 
 
For leaks involving liquids containing PCBs, such as those found in old fluorescent light ballasts, 
the EPA requires special source removal and waste disposal procedures.[4,8] EPA indicates 
that building owners should consider proactive replacement of PCB-containing light fixtures as a 
cost-saving control measure as compared to the significant costs for PCB clean-up and building 
occupant displacement associated with a ballast leak or failure.  
 
If PCBs have contaminated the adjacent soil and concentrations exceed 1 ppm, the soil is 
considered PCB remediation waste and is subject to the cleanup and disposal requirements 
specified under 40 CFR 761.61. As such, excavation of PCB-contaminated soils that result from 
spills or releases from PCB-containing building materials, as well as from improper abatement, 
handling and disposal practices, may be required in some instances.  
 
11.2 Mitigation 
 
PCB mitigation is an interim control measure intended to limit PCB release from building 
materials, reduce airborne and surface PCB accumulations inside buildings, and minimize 
exposure of building occupants to PCB sources. If properly planned and implemented, 
mitigation methods may be as effective as permanent controls in the protection of human and 
environmental health. Mitigation, which is often a complement to abatement methods, includes 
engineering and administrative control measures, which can be employed individually or in 
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various combinations. Priorities for mitigation efforts should be based on the material’s PCB 
concentration, condition, accessibility and building occupancy. [8,77,78,79] 
 
11.2.1 Engineering Controls 
 
Engineering controls are modifications to the building’s systems and structures that serve to 
reduce the exposure potential of building occupants to PCB sources and releases. Engineering 
controls in this application include encapsulation, physical barriers (enclosure), ventilation and 
air cleaning. 
 
Encapsulation involves covering PCB sources such as caulk, paints and adhesive with an 
impermeable film or sealant to reduce the potential for dermal contact and to reduce PCB 
release through mechanical disturbance, deterioration (aging) or volatilization.[8,77,78,79] 
Encapsulants include tapes, sealants (acrylic, polyurethane and silicone) and epoxy coatings. 
Epoxy coatings have been widely used in joints after caulk removal. In an April 2012 publication, 
the EPA reported the major findings of its laboratory study of various encapsulating 
materials.[80] The report noted that encapsulation was most effective for contaminated surfaces 
with low PCB levels (maximum allowable PCB concentration was estimated to be 430 ppm), 
that multiple layers of coatings enhance performance, and that encapsulation offers a significant 
cost reduction by not removing PCB-contaminated secondary source materials (e.g., brick, 
concrete) from buildings. The EPA indicated that the encapsulation of primary sources, such as 
old caulk, which contain high PCB concentrations, may not adequately reduce air and surface 
PCB concentrations to recommended levels. EPA also cautioned that building owners need to 
implement long-term inspection and monitoring plans to ensure encapsulant seals remain intact. 
PCBs have been shown to transfer from secondary sources to encapsulating products intended 
to inhibit PCB migration. In one reported case, new silicone caulk applied directly to PCB-
containing caulk absorbed the PCBs and reached levels up to 4,200 ppm.[8] 
 
Physical barriers include the use of interior walls, sealants and foam to enclose PCB sources. 
Fences have been used to prevent access to exterior PCB-containing building materials. 
Geofabrics, clean stone and new landscaping mulch have been used to prevent access to 
contaminated soils resulting from disturbance or degradation of exterior PCB-containing building 
materials.  
 
Increased building ventilation with outdoor air (greater than 5 air exchanges per hour) has been 
shown to reduce PCB concentrations in indoor air.[8] Energy costs due to heating and cooling of 
outdoor air may be significant for building owners. The building ventilation system should be 
checked to ensure that it is functioning as designed and, if necessary, owners should make 
appropriate repairs to increase or improve ventilation. Exhaust fans can be added to improve 
removal of air contaminants.  
 
If elevated levels of airborne PCBs are found in a mechanically ventilated building, the 
ventilation system should be evaluated to determine if it is contaminated with PCBs. Although it 
is unlikely that the ventilation system is the original source of PCB contamination, it could be 
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contaminated from other sources of PCBs and be contributing to the overall airborne levels. 
Contaminated ventilation systems should be carefully cleaned and, if possible, such cleaning 
should be conducted at the same time as the removal of any known sources of PCBs in order to 
avoid re-contamination of the system. The use of air cleaners equipped with activated charcoal 
filters operating at 400 cubic feet of air per minute (cfm) was shown to be effective in the 
reduction of indoor airborne PCB concentrations in one study.[8] 
 
11.2.2 Administrative Controls 
 
Administrative controls involve changes to the use or maintenance of a building that reduce the 
magnitude of potential occupant exposure to PCBs or the likelihood of uncontrolled PCB 
releases from source materials. Building spaces with low PCB exposure potential (e.g., storage 
areas, attics, etc.) or confirmed indoor air concentrations well below established indoor air 
targets are good locations for implementation of administrative controls. Special consideration 
should be given to vulnerable populations (i.e., young children) to ensure that accessibility and 
exposure to primary and secondary PCB sources are prevented.  
 
Operations and maintenance (O&M) plans for residual PCBs in building materials should be a 
major component of an overall facility management plan. O&M plans should address PCB 
source materials and concentrations, locations, conditions, accessibility, abatement and 
mitigation controls in place, inspections, work practices and controls for contacting and cleaning 
PCB source materials and the need for additional remediation actions. The O&M plan should 
also include provisions for periodic air and surface sampling to assess PCB concentrations and 
effectiveness of mitigation controls and awareness training of building occupants.  
 
Management-in-place of PCB-containing building materials can present significant costs to 
building owners.[8,79] Prohibited work practices, such as use of compressed air and dry 
sweeping and dusting, should be clearly identified in the O&M plans. Building occupants and 
workers should be instructed to avoid or minimize direct contact with PCB-containing materials. 
For caulk used on windows, walls, columns and other vertical structures that occupants may 
contact, metallic tape can be used to isolate the material so that caulk or dust and debris from 
the surrounding masonry do not escape. The metallic tape should cover the caulk and 
surrounding areas of masonry.  
 
In addition, disintegrating PCB caulk, paints and other coatings may also shed dust that can 
contaminate window sills and other nearby surfaces. Best management practices should be 
developed for dealing with dust, including: 
o Frequent cleaning to reduce dust and residue inside buildings;  
o Using wet or damp cloths and/or mops to clean surfaces;  
o Using vacuums equipped with high efficiency particulate air (HEPA) filters;  
o Do not dry sweep and minimize the use of dusters;  
o Wear the appropriate protective clothing when conducting this cleanup;  
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o Dispose of all cleanup materials (mops, rags, filters, water, etc.) in accordance 
with all federal, state, and county regulations; and 
o Wash hands and face with soap and water after cleaning, and before eating or 
drinking.  
 
11.3 Remediation Work Plans 
 
U.S. EPA PCB regulations require that a work plan be prepared prior to starting any PCB 
remediation action in a building. [4] The self-implementing procedures required by the EPA for 
removal or cleanup of PCB-contaminated building materials require notification and submission 
of a work plan to the EPA at least 30 days prior to the site cleanup under 40 CFR 761.61. The 
plan must include description of abatement and mitigation activities, proposed cleanup levels, 
removal and abatement procedures, verification sampling procedures, waste storage and 
handling procedures and disposal options.  
 
As previously stated in this paper, building owners should also confirm the presence of asbestos 
and lead in the suspect or identified PCB-containing building materials. Work plans should 
identify the additional hazardous materials and contractor workers must meet OSHA, state and 
local requirements for abatement of these materials. 
A California study evaluated the potential impacts of PCB-containing caulks and sealants 
released into storm water runoff during building demolition and renovation projects and a Model 
Implementation Process has been initially proposed to establish a regulatory process to manage 
PCBs in caulks and sealants to protect water quality.[76] Similar to building demolition projects 
involving asbestos and lead, industrial hygienists can play a significant role in community and 
environmental protection through careful planning and oversight of work area containment, dust 
suppression methods, site erosion and sediment controls and protection of storm water drains.  
 
11.4 Evaluation of Remediation Methods 
 
The EPA’s PCB regulations (40 CFR 761) do not specify a schedule for the determination of 
PCB-containing materials as waste or for the remediation of PCB waste.[4] Building owners are 
thus able to evaluate site-specific conditions, various remediation options, establish practical 
remediation goals and select the remediation strategy that is most appropriate for their buildings 
with PCB-containing materials. Building owners should also understand that interim control of 
identified PCB releases to the environment may be required while options for permanent 
remedies are evaluated. Significant costs are associated with managing PCBs in place.  
 
Several studies have demonstrated that the available abatement and mitigation methods are 
effective for complying with current PCB regulations, especially when multiple methods are used 
concurrently for PCB hazard reduction. Additional factors that may drive a remedial response 
are PCB concentrations in indoor air and surface dust, regardless of the PCB content of the 
building materials themselves. 
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11.5 Post-Remediation Verification 
 
40 CFR 761.79 provides for measurement-based methods (i.e., post-remediation wipe sampling 
and analysis) as well as performance-based methods (e.g., incineration). These may proceed 
without prior EPA approval. However, if an alternate remediation strategy is to be used, then 
EPA approval must be obtained. This rule defines decontamination standards and procedures 
for the removal of PCBs from a variety of media, such as water, concrete, organic liquids, and 
non-porous surfaces. For the built/building environment, there are two specific applications: 
concrete and non-porous surfaces covered with a porous surface, such as paint or coatings on 
metals. 
 
40 CFR 761.79(f) requires confirmatory sampling per Subpart P, which addresses sampling of 
wastes for proper disposal methods under 761.61(a)(6), as well as decontamination verification 
under 761.79 (b)(3). 
 
Decontamination verification for abated non-porous surfaces that were covered with PCB paint 
or caulk is a visual examination followed by a standard wipe test per 761.123. A variety of 
solvents may be selected for sampling, but many of these solvents are flammable and have 
their own toxicity concerns. A wipe sample is typically acquired from a 10 centimeter by 10 
centimeter surface area; sufficient numbers of samples must be collected to meet statistical 
treatments. 
 
11.6 Personal Protective Equipment 
 
Workers performing PCB remediation normally wear disposable whole body clothing and shoe 
covers, respiratory protection, chemical-resistant gloves, and safety glasses or protective 
goggles to protect against inhalation and dermal exposure to PCBs.  
 
As noted above, in addition to PCBs, caulking and other construction materials may also contain 
lead or asbestos. In many cases remediation should proceed in a manner similar to lead or 
asbestos removal. While there are no nationally recognized PCB removal certifications, facility 
owners may want to consider utilizing contractors with AHERA or RRP abatement certifications. 
 
 Respirators – air purifying respirators are typically worn by workers during remediation 
work. While half facepiece respirators may be acceptable based on the exposure levels, 
some employers prefer to use full facepiece respirators or powered air purifying 
respirators (PAPRs). Both full-facepiece (with quantitative fit testing) and PAPRs provide 
higher assigned protection factors than half-facepiece respirators. The full-facepiece 
respirator also provides eye protection and additional skin protection by covering the 
whole face. PAPRs, when used with hoods or helmets, can protect the entire head, neck 
and shoulder area. Depending on the system, PAPRs may offer additional advantages, 
such as allowing limited facial hair and waiving of fit-testing. PCBs are primarily a 
particulate hazard and a P95 filter would be appropriate. However, a P100 filter is 
required if lead or asbestos co-exists with the PCBs. Therefore, employers may want to 
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consider routine use of P100 filters as a precaution in case previously unidentified 
asbestos or lead is encountered during remediation. At this time, PAPRs use only the 
high efficiency (HE) designation – not 95 or 100 designations. 
 
PCBs may also be present in a vapor form, especially if the material has been heated. If 
there is any possibility of a vapor phase being present, employers should use a 
combination P100/organic vapor cartridge.[81] A respiratory protection program that 
complies with the requirements of 29 CFR Part 1910.134 must be established. 
Respirator users must understand and follow the respirator user instructions and any 
other manufacturer’s recommendations and warnings. 
 
 Worker protective clothing (WPC) – Full-body WPC should be worn during remediation 
to minimize skin contact and also to minimize the risk of bringing contaminated clothing 
back to the worker’s home. Employers may want to look for WPC that meets the 
requirements of EN ISO 13982-1 Type 5 - Protective Clothing for Use against Solid 
Particles or ANSI/ISEA 103-2010 American National Standard for Classification and 
Performance Requirements for Chemical Protective Clothing.[82,83] 
 
 Gloves – PCBs may be absorbed to a significant extent through the skin. Therefore, 
chemical-protective gloves should be worn when handling PCB-contaminated material. 
EPA suggests using gloves made of nitrile butadiene rubber.[81] Butyl rubber or 
neoprene may also offer sufficient protection for incidental contact during 
remediation.[84] The glove manufacturer should always be consulted to determine the 
best product for the specific tasks and expected exposures. 
 
11.7 Training 
 
Training for remediation workers should, at a minimum, include the following: 
 Location of PCB-containing materials in the worksite; 
 Hazard Communication training for PCBs that, at a minimum, meets the requirements of 
29 CFR 1910.1200 and the importance of minimizing worker exposure (both inhalation 
and skin exposure);  
 Other hazardous materials (e.g. lead, asbestos) that may also be present. If present, 
training and other requirements per 29 CFR 1926.62 and 29 CFR 1926.1101 must be 
followed; 
 Engineering controls that will be used to minimize release of PCB materials (e.g. HEPA 
filtered vacuums, wet methods, local exhausted power tools);  
 Eating, drinking and smoking are prohibited during handling of PCB materials and not 
allowed until required decontamination has been completed; and 
 Proper inspection, use, cleaning, and storage of PPE per the manufacturer’s user 
instructions. Eating, drinking and smoking are prohibited during handling of PCB 
materials and not allowed until required decontamination has been completed. 
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11.8 Waste Disposal  
 
11.8.1 PCB Waste Categories 
 
Under 40 CFR 761.3, a building material that is identified as an unauthorized use of PCBs and 
designated for disposal must be properly classified as either a PCB Bulk Product Waste or a 
PCB Remediation Waste. Materials that were “manufactured, coated or serviced with PCBs” 
and that contain 50 ppm or greater PCBs are subject to the requirements for PCB Bulk Product 
Waste. Primary sources of PCB-containing building materials such as caulks, glazing, mastics, 
sealants, paints and surface coatings are generally classified as PCB Bulk Product Waste.  
 
On October 24, 2012, EPA issued a memorandum on the proposed reinterpretation of the PCB 
Bulk Product Waste definition noting that building materials (i.e., substrates) that are “coated or 
serviced with PCB Bulk Product Waste (e.g., caulk, paint, mastic, sealants) at the time of 
designation of disposal are to be managed as a PCB bulk product waste, even if the PCBs have 
migrated from the overlying bulk product waste into the substrate, provided there is no other 
source of PCB contamination on or in the substrate.”[85] If the bulk product waste has been 
removed or separated (no longer coated or serviced) from the substrate at the time of 
designation for disposal and the substrate is contaminated with PCBs that have migrated from 
the bulk product waste, the substrate would be considered a PCB remediation waste. EPA 
recommends that the building owner document in the abatement plan the decision to designate 
building materials as bulk product waste at the time of designation for disposal. EPA notes that 
this proposed reinterpretation will allow for prompt PCB removal and disposal and thereby 
reduce potential exposure of building occupants and workers. EPA notes that it received no 
opposition in public comments to its proposed reinterpretation. 
 
Secondary sources or materials that contain PCBs as a result of a release from primary sources 
are subject to the PCB Remediation Waste regulations. These include building materials such 
as brick, concrete and other building materials contaminated by PCB spills, waste materials 
from clean-up activities, and contaminated soil. Leaching is considered by EPA to be a release 
of PCBs.  
 
11.8.2 Waste Disposal  
 
Disposal options for PCB Bulk Product Waste (40 CFR Part 761.62) include performance-based 
disposal by landfill, incineration or decontamination at a Resource Conservation and Recovery 
Act (RCRA) permitted facility. EPA may also approve a risk-based disposal method if it can be 
demonstrated that it will not pose an unreasonable risk of injury to health or the environment. 
 
EPA regulations allow PCB Remediation Waste to be managed according to a method that is 
termed self-implementing onsite clean-up and disposal. This disposal option allows residual 
levels of PCB Remediation Waste to remain in a building, the amount depending on the use 
characteristics of the property and the disposition of the PCBs: high occupancy (e.g., school 
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classroom, plant assembly line, cafeteria) versus low occupancy (e.g., non-office space in a 
warehouse or electrical equipment vault) areas; bulk concentrations versus surface loading 
levels; and unrestricted land use versus a deed restriction. The surface clearance criteria for 
PCB Remediation Waste for a nonporous surface is less than or equal to ten micrograms of 
PCBs per 100 square centimeters (µg/100 cm2) in a high-occupancy area and less than 100 
µg/100 cm2 for a low-occupancy area.[4,8] The clearance criteria for PCB Remediation Waste 
for a bulk or porous material is less than or equal to one ppm in a high-occupancy area and less 
than or equal to 25 ppm in a low-occupancy area.[4,8] 
 
12.0 DISCUSSION  
 
Review of the current state of PCB knowledge has identified critical information gaps pertaining 
to the health risks that PCBs in the built environment may pose to occupants and workers. 
While it is beyond the scope of this white paper to quantify the risk of PCBs ingested from 
contaminated food, as compared to the risk associated with exposure to PCBs arising from the 
built environment, it should be kept in mind that most of the human PCB exposure historically 
has been mainly through the ingestion of contaminated food or from occupational exposures 
(e.g. manufacturing PCB-containing components, etc.). The health risks posed by PCBs in the 
built environment are not well understood. Hence, improved exposure assessments in the built 
environment are necessary to further understand the short and long-term risks to building 
occupants, building maintenance and construction personnel from PCB-containing construction 
materials.  
 
Some of the potentially significant data gaps identified include: 
 
 The paucity of exposure assessment data with congener-specific identification and 
resulting exposure profiles to building occupants, maintenance personnel and 
construction workers. In addition, there is inconsistency within published studies on the 
selection of congeners studied; some use methods of analysis that provide results for 
prescribed congeners, while others attempt to link source-confirmed congeners to air 
sampling data. There is a need for standardized approaches to the selection of 
congeners under study in the built environment, whether for biological, environmental or 
structural characterization purposes. 
 
 There is a lack of complete exposure profiles across the variety of building types, with 
consideration of the populations occupying them. Few of the studies cited reported on 
occupancy characteristics of the populations (i.e., times of day and days of week the 
building was occupied, etc.), which would serve to refine risk and exposure assessments 
from source materials. 
 
 In the United States, current TSCA regulations do not require identification of PCB- 
containing building materials, unless activities are planned that may generate PCB 
wastes (i.e. renovation or demolition activities). Additionally, very few international 
regulations have, as a starting point, an obligation to identify and confirm open sources 
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of PCBs. As a result, many environments with PCB exposures go unrecognized, or are 
mischaracterized because the primary exposure sources may be unidentified (such as 
assessing airborne concentrations of PCBs released from PCB-containing caulk when 
concrete in the same room had previously been contaminated from leaking light 
ballasts). Thorough hazard identification should always be the first step prior to 
determining risk to the occupants. 
 
 Currently prescribed respiratory protection levels for abatement/remediation/mitigation 
activities do not appear to suitably address work involving PCBs in their vapor phase. 
The use of air-purifying respiratory protection equipped with combination HEPA/organic 
vapor cartridges is recommended. 
 
 Non-legacy PCBs in pigments continue to be produced. Such pigments may have 
consequences related to human health and the environment through contaminated 
drinking water or bioaccumulation in the food chain.  
 
13.0 CONCLUSION  
 
This white paper has reviewed and summarized the current scientific body of knowledge with 
respect to the hazard identification, exposure assessment and risk management related to 
PCBs in the built environment. In support of AIHA’s current strategic plan, and based on a 
review of the issue, the authors call attention to the following needs for the development of 
public policy based on sound science. AIHA can assist in this endeavor by: 
 
1. Promoting the need for additional scientific research into the relative exposure risks 
posed by PCB-containing building materials to building occupants, maintenance and 
construction personnel; and 
 
2. Encouraging the collection of exposure assessment data by the industrial hygiene and 
scientific community to confirm and verify the extent of any such risks. 
Development of PCB exposure assessment profiles for building occupants, as well as 
maintenance and construction personnel, can lead to a better understanding of the populations 
most at risk from PCBs in building materials. Risk assessment analyses, based on more 
comprehensive exposure data, could then serve as the technical basis for possible regulatory 
changes to help ensure that human health and the environment are appropriately protected 
based on an improved understanding of the role that PCBs in building materials may play in the 
overall exposure risk from PCBs (i.e. dietary versus building environment exposures).   
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Appendix A: PCB Species by Congener Number 
 
IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
Biphenyl 0 92-52-4 
 
2-Chlorobiphenyl 1 2051-60-7 CP1 
3-Chlorobiphenyl 2 2051-61-8 CP0 
4-Chlorobiphenyl 3 2051-62-9 CP0 
2,2'-Dichlorobiphenyl 4 13029-08-8 
 
2,3-Dichlorobiphenyl 5 16605-91-7 CP1 
2,3'-Dichlorobiphenyl 6 25569-80-6 CP1 
2,4-Dichlorobiphenyl 7 33284-50-3 CP1 
2,4'-Dichlorobiphenyl 8 34883-43-7 CP1 
2,5-Dichlorobiphenyl 9 34883-39-1 CP1 
2,6-Dichlorobiphenyl 10 33146-45-1 
 
3,3'-Dichlorobiphenyl 11 2050-67-1 CP0, 2M 
3,4-Dichlorobiphenyl 12 2974-92-7 CP0 
3,4'-Dichlorobiphenyl 13 2974-90-5 CP0 
3,5-Dichlorobiphenyl 14 34883-41-5 CP0, 2M 
4,4'-Dichlorobiphenyl 15 2050-68-2 CP0, PP 
2,2',3-Trichlorobiphenyl 16 38444-78-9 
 
2,2',4-Trichlorobiphenyl 17 37680-66-3 
 
2,2',5-Trichlorobiphenyl 18 37680-65-2 
 
2,2',6-Trichlorobiphenyl 19 38444-73-4 
 
2,3,3'-Trichlorobiphenyl 20 38444-84-7 CP1, 2M 
American Industrial Hygiene Association®  PCBs in the Built Environment White Paper 
 P a g e  | 36 
IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,3,4-Trichlorobiphenyl 21 55702-46-0 CP1 
2,3,4'-Trichlorobiphenyl 22 38444-85-8 CP1 
2,3,5-Trichlorobiphenyl 23 55720-44-0 CP1, 2M 
2,3,6-Trichlorobiphenyl 24 55702-45-9 
 
2,3',4-Trichlorobiphenyl 25 55712-37-3 CP1 
2,3',5-Trichlorobiphenyl 26 38444-81-4 CP1, 2M 
2,3',6-Trichlorobiphenyl 27 38444-76-7 
 
2,4,4'-Trichlorobiphenyl 28 7012-37-5 CP1, PP 
2,4,5-Trichlorobiphenyl 29 15862-07-4 CP1 
2,4,6-Trichlorobiphenyl 30 35693-92-6 
 
2,4',5-Trichlorobiphenyl 31 16606-02-3 CP1 
2,4',6-Trichlorobiphenyl 32 38444-77-8 
 
2,3',4'-Trichlorobiphenyl 33 38444-86-9 CP1 
2,3',5'-Trichlorobiphenyl 34 37680-68-5 CP1, 2M 
3,3',4-Trichlorobiphenyl 35 37680-69-6 CP0, 2M 
3,3',5-Trichlorobiphenyl 36 38444-87-0 CP0, 2M 
3,4,4'-Trichlorobiphenyl 37 38444-90-5 CP0, PP 
3,4,5-Trichlorobiphenyl 38 53555-66-1 CP0, 2M 
3,4',5-Trichlorobiphenyl 39 38444-88-1 CP0, 2M 
2,2',3,3'-Tetrachlorobiphenyl 40 38444-93-8 4CL, 2M 
2,2',3,4-Tetrachlorobiphenyl 41 52663-59-9 4CL 
2,2',3,4'-Tetrachlorobiphenyl 42 36559-22-5 4CL 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,2',3,5-Tetrachlorobiphenyl 43 70362-46-8 4CL, 2M 
2,2',3,5'-Tetrachlorobiphenyl 44 41464-39-5 4CL, 2M 
2,2',3,6-Tetrachlorobiphenyl 45 70362-45-7 4CL 
2,2',3,6'-Tetrachlorobiphenyl 46 41464-47-5 4CL 
2,2',4,4'-Tetrachlorobiphenyl 47 2437-79-8 4CL, PP 
2,2',4,5-Tetrachlorobiphenyl 48 70362-47-9 4CL 
2,2',4,5'-Tetrachlorobiphenyl 49 41464-40-8 4CL 
2,2',4,6-Tetrachlorobiphenyl 50 62796-65-0 4CL 
2,2',4,6'-Tetrachlorobiphenyl 51 68194-04-7 4CL 
2,2',5,5'-Tetrachlorobiphenyl 52 35693-99-3 4CL, 2M 
2,2',5,6'-Tetrachlorobiphenyl 53 41464-41-9 4CL 
2,2',6,6'-Tetrachlorobiphenyl 54 15968-05-5 4CL 
2,3,3',4-Tetrachlorobiphenyl 55 74338-24-2 CP1, 4CL, 2M 
2,3,3',4'-Tetrachlorobiphenyl 56 41464-43-1 CP1, 4CL, 2M 
2,3,3',5-Tetrachlorobiphenyl 57 70424-67-8 CP1, 4CL, 2M 
2,3,3',5'-Tetrachlorobiphenyl 58 41464-49-7 CP1, 4CL, 2M 
2,3,3',6-Tetrachlorobiphenyl 59 74472-33-6 4CL, 2M 
2,3,4,4'-Tetrachlorobiphenyl 60 33025-41-1 CP1, 4CL, PP 
2,3,4,5-Tetrachlorobiphenyl 61 33284-53-6 CP1, 4CL, 2M 
2,3,4,6-Tetrachlorobiphenyl 62 54230-22-7 4CL 
2,3,4',5-Tetrachlorobiphenyl 63 74472-34-7 CP1, 4CL, 2M 
2,3,4',6-Tetrachlorobiphenyl 64 52663-58-8 4CL 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,3,5,6-Tetrachlorobiphenyl 65 33284-54-7 4CL, 2M 
2,3',4,4'-Tetrachlorobiphenyl 66 32598-10-0 CP1, 4CL, PP 
2,3',4,5-Tetrachlorobiphenyl 67 73575-53-8 CP1, 4CL, 2M 
2,3',4,5'-Tetrachlorobiphenyl 68 73575-52-7 CP1, 4CL, 2M 
2,3',4,6-Tetrachlorobiphenyl 69 60233-24-1 4CL 
2,3',4',5-Tetrachlorobiphenyl 70 32598-11-1 CP1, 4CL, 2M 
2,3',4',6-Tetrachlorobiphenyl 71 41464-46-4 4CL 
2,3',5,5'-Tetrachlorobiphenyl 72 41464-42-0 CP1, 4CL, 2M 
2,3',5',6-Tetrachlorobiphenyl 73 74338-23-1 4CL, 2M 
2,4,4',5-Tetrachlorobiphenyl 74 32690-93-0 CP1, 4CL, PP 
2,4,4',6-Tetrachlorobiphenyl 75 32598-12-2 4CL, PP 
2,3',4',5'-Tetrachlorobiphenyl 76 70362-48-0 CP1, 4CL, 2M 
3,3',4,4'-Tetrachlorobiphenyl 77 32598-13-3 CP0, 4CL, PP, 2M 
3,3',4,5-Tetrachlorobiphenyl 78 70362-49-1 CP0, 4CL, 2M 
3,3',4,5'-Tetrachlorobiphenyl 79 41464-48-6 CP0, 4CL, 2M 
3,3',5,5'-Tetrachlorobiphenyl 80 33284-52-5 CP0, 4CL, 2M 
3,4,4',5-Tetrachlorobiphenyl 81 70362-50-4 CP0, 4CL, PP, 2M 
2,2',3,3',4-Pentachlorobiphenyl 82 52663-62-4 4CL, 2M 
2,2',3,3',5-Pentachlorobiphenyl 83 60145-20-2 4CL, 2M 
2,2',3,3',6-Pentachlorobiphenyl 84 52663-60-2 4CL, 2M 
2,2',3,4,4'-Pentachlorobiphenyl 85 65510-45-4 4CL, PP 
2,2',3,4,5-Pentachlorobiphenyl 86 55312-69-1 4CL, 2M 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,2',3,4,5'-Pentachlorobiphenyl 87 38380-02-8 4CL, 2M 
2,2',3,4,6-Pentachlorobiphenyl 88 55215-17-3 4CL 
2,2',3,4,6'-Pentachlorobiphenyl 89 73575-57-2 4CL 
2,2',3,4',5-Pentachlorobiphenyl 90 68194-07-0 4CL, 2M 
2,2',3,4',6-Pentachlorobiphenyl 91 68194-05-8 4CL 
2,2',3,5,5'-Pentachlorobiphenyl 92 52663-61-3 4CL, 2M 
2,2',3,5,6-Pentachlorobiphenyl 93 73575-56-1 4CL, 2M 
2,2',3,5,6'-Pentachlorobiphenyl 94 73575-55-0 4CL, 2M 
2,2',3,5',6-Pentachlorobiphenyl 95 38379-99-6 4CL, 2M 
2,2',3,6,6'-Pentachlorobiphenyl 96 73575-54-9 4CL 
2,2',3,4',5'-Pentachlorobiphenyl 97 41464-51-1 4CL, 2M 
2,2',3,4',6'-Pentachlorobiphenyl 98 60233-25-2 4CL 
2,2',4,4',5-Pentachlorobiphenyl 99 38380-01-7 4CL, PP 
2,2',4,4',6-Pentachlorobiphenyl 100 39485-83-1 4CL, PP 
2,2',4,5,5'-Pentachlorobiphenyl 101 37680-73-2 4CL, 2M 
2,2',4,5,6'-Pentachlorobiphenyl 102 68194-06-9 4CL 
2,2',4,5',6-Pentachlorobiphenyl 103 60145-21-3 4CL 
2,2',4,6,6'-Pentachlorobiphenyl 104 56558-16-8 4CL 
2,3,3',4,4'-Pentachlorobiphenyl 105 32598-14-4 CP1, 4CL, PP, 2M 
2,3,3',4,5-Pentachlorobiphenyl 106 70424-69-0 CP1, 4CL, 2M 
2,3,3',4',5-Pentachlorobiphenyl 107 70424-68-9 CP1, 4CL, 2M 
2,3,3',4,5'-Pentachlorobiphenyl 108 70362-41-3 CP1, 4CL, 2M 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,3,3',4,6-Pentachlorobiphenyl 109 74472-35-8 4CL, 2M 
2,3,3',4',6-Pentachlorobiphenyl 110 38380-03-9 4CL, 2M 
2,3,3',5,5'-Pentachlorobiphenyl 111 39635-32-0 CP1, 4CL, 2M 
2,3,3',5,6-Pentachlorobiphenyl 112 74472-36-9 4CL, 2M 
2,3,3',5',6-Pentachlorobiphenyl 113 68194-10-5 4CL, 2M 
2,3,4,4',5-Pentachlorobiphenyl 114 74472-37-0 CP1, 4CL, PP, 2M 
2,3,4,4',6-Pentachlorobiphenyl 115 74472-38-1 4CL, PP 
2,3,4,5,6-Pentachlorobiphenyl 116 18259-05-7 4CL, 2M 
2,3,4',5,6-Pentachlorobiphenyl 117 68194-11-6 4CL, 2M 
2,3',4,4',5-Pentachlorobiphenyl 118 31508-00-6 CP1, 4CL, PP, 2M 
2,3',4,4',6-Pentachlorobiphenyl 119 56558-17-9 4CL, PP 
2,3',4,5,5'-Pentachlorobiphenyl 120 68194-12-7 CP1, 4CL, 2M 
2,3',4,5',6-Pentachlorobiphenyl 121 56558-18-0 4CL, 2M 
2,3,3',4',5'-Pentachlorobiphenyl 122 76842-07-4 CP1, 4CL, 2M 
2,3',4,4',5'-Pentachlorobiphenyl 123 65510-44-3 CP1, 4CL, PP, 2M 
2,3',4',5,5'-Pentachlorobiphenyl 124 70424-70-3 CP1, 4CL, 2M 
2,3',4',5',6-Pentachlorobiphenyl 125 74472-39-2 4CL, 2M 
3,3',4,4',5-Pentachlorobiphenyl 126 57465-28-8 CP0, 4CL, PP, 2M 
3,3',4,5,5'-Pentachlorobiphenyl 127 39635-33-1 CP0, 4CL, 2M 
2,2',3,3',4,4'-Hexachlorobiphenyl 128 38380-07-3 4CL, PP, 2M 
2,2',3,3',4,5-Hexachlorobiphenyl 129 55215-18-4 4CL, 2M 
2,2',3,3',4,5'-Hexachlorobiphenyl 130 52663-66-8 4CL, 2M 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,2',3,3',4,6-Hexachlorobiphenyl 131 61798-70-7 4CL, 2M 
2,2',3,3',4,6'-Hexachlorobiphenyl 132 38380-05-1 4CL, 2M 
2,2',3,3',5,5'-Hexachlorobiphenyl 133 35694-04-3 4CL, 2M 
2,2',3,3',5,6-Hexachlorobiphenyl 134 52704-70-8 4CL, 2M 
2,2',3,3',5,6'-Hexachlorobiphenyl 135 52744-13-5 4CL, 2M 
2,2',3,3',6,6'-Hexachlorobiphenyl 136 38411-22-2 4CL, 2M 
2,2',3,4,4',5-Hexachlorobiphenyl 137 35694-06-5 4CL, PP, 2M 
2,2',3,4,4',5'-Hexachlorobiphenyl 138 35065-28-2 4CL, PP, 2M 
2,2',3,4,4',6-Hexachlorobiphenyl 139 56030-56-9 4CL, PP 
2,2',3,4,4',6'-Hexachlorobiphenyl 140 59291-64-4 4CL, PP 
2,2',3,4,5,5'-Hexachlorobiphenyl 141 52712-04-6 4CL, 2M 
2,2',3,4,5,6-Hexachlorobiphenyl 142 41411-61-4 4CL, 2M 
2,2',3,4,5,6'-Hexachlorobiphenyl 143 68194-15-0 4CL, 2M 
2,2',3,4,5',6-Hexachlorobiphenyl 144 68194-14-9 4CL, 2M 
2,2',3,4,6,6'-Hexachlorobiphenyl 145 74472-40-5 4CL 
2,2',3,4',5,5'-Hexachlorobiphenyl 146 51908-16-8 4CL, 2M 
2,2',3,4',5,6-Hexachlorobiphenyl 147 68194-13-8 4CL, 2M 
2,2',3,4',5,6'-Hexachlorobiphenyl 148 74472-41-6 4CL, 2M 
2,2',3,4',5',6-Hexachlorobiphenyl 149 38380-04-0 4CL, 2M 
2,2',3,4',6,6'-Hexachlorobiphenyl 150 68194-08-1 4CL 
2,2',3,5,5',6-Hexachlorobiphenyl 151 52663-63-5 4CL, 2M 
2,2',3,5,6,6'-Hexachlorobiphenyl 152 68194-09-2 4CL, 2M 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,2',4,4',5,5'-Hexachlorobiphenyl 153 35065-27-1 4CL, PP, 2M 
2,2',4,4',5,6'-Hexachlorobiphenyl 154 60145-22-4 4CL, PP 
2,2',4,4',6,6'-Hexachlorobiphenyl 155 33979-03-2 4CL, PP 
2,3,3',4,4',5-Hexachlorobiphenyl 156 38380-08-4 CP1, 4CL, PP, 2M 
2,3,3',4,4',5'-Hexachlorobiphenyl 157 69782-90-7 CP1, 4CL, PP, 2M 
2,3,3',4,4',6-Hexachlorobiphenyl 158 74472-42-7 4CL, PP, 2M 
2,3,3',4,5,5'-Hexachlorobiphenyl 159 39635-35-3 CP1, 4CL, 2M 
2,3,3',4,5,6-Hexachlorobiphenyl 160 41411-62-5 4CL, 2M 
2,3,3',4,5',6-Hexachlorobiphenyl 161 74472-43-8 4CL, 2M 
2,3,3',4',5,5'-Hexachlorobiphenyl 162 39635-34-2 CP1, 4CL, 2M 
2,3,3',4',5,6-Hexachlorobiphenyl 163 74472-44-9 4CL, 2M 
2,3,3',4',5',6-Hexachlorobiphenyl 164 74472-45-0 4CL, 2M 
2,3,3',5,5',6-Hexachlorobiphenyl 165 74472-46-1 4CL, 2M 
2,3,4,4',5,6-Hexachlorobiphenyl 166 41411-63-6 4CL, PP, 2M 
2,3',4,4',5,5'-Hexachlorobiphenyl 167 52663-72-6 CP1, 4CL, PP, 2M 
2,3',4,4',5',6-Hexachlorobiphenyl 168 59291-65-5 4CL, PP, 2M 
3,3',4,4',5,5'-Hexachlorobiphenyl 169 32774-16-6 CP0, 4CL, PP, 2M 
2,2',3,3',4,4',5-Heptachlorobiphenyl 170 35065-30-6 4CL, PP, 2M 
2,2',3,3',4,4',6-Heptachlorobiphenyl 171 52663-71-5 4CL, PP, 2M 
2,2',3,3',4,5,5'-Heptachlorobiphenyl 172 52663-74-8 4CL, 2M 
2,2',3,3',4,5,6-Heptachlorobiphenyl 173 68194-16-1 4CL, 2M 
2,2',3,3',4,5,6'-Heptachlorobiphenyl 174 38411-25-5 4CL, 2M 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,2',3,3',4,5',6-Heptachlorobiphenyl 175 40186-70-7 4CL, 2M 
2,2',3,3',4,6,6'-Heptachlorobiphenyl 176 52663-65-7 4CL, 2M 
2,2',3,3',4,5',6'-Heptachlorobiphenyl 177 52663-70-4 4CL, 2M 
2,2',3,3',5,5',6-Heptachlorobiphenyl 178 52663-67-9 4CL, 2M 
2,2',3,3',5,6,6'-Heptachlorobiphenyl 179 52663-64-6 4CL, 2M 
2,2',3,4,4',5,5'-Heptachlorobiphenyl 180 35065-29-3 4CL, PP, 2M 
2,2',3,4,4',5,6-Heptachlorobiphenyl 181 74472-47-2 4CL, PP, 2M 
2,2',3,4,4',5,6'-Heptachlorobiphenyl 182 60145-23-5 4CL, PP, 2M 
2,2',3,4,4',5',6-Heptachlorobiphenyl 183 52663-69-1 4CL, PP, 2M 
2,2',3,4,4',6,6'-Heptachlorobiphenyl 184 74472-48-3 4CL, PP 
2,2',3,4,5,5',6-Heptachlorobiphenyl 185 52712-05-7 4CL, 2M 
2,2',3,4,5,6,6'-Heptachlorobiphenyl 186 74472-49-4 4CL, 2M 
2,2',3,4',5,5',6-Heptachlorobiphenyl 187 52663-68-0 4CL, 2M 
2,2',3,4',5,6,6'-Heptachlorobiphenyl 188 74487-85-7 4CL, 2M 
2,3,3',4,4',5,5'-Heptachlorobiphenyl 189 39635-31-9 CP1, 4CL, PP, 2M 
2,3,3',4,4',5,6-Heptachlorobiphenyl 190 41411-64-7 4CL, PP, 2M 
2,3,3',4,4',5',6-Heptachlorobiphenyl 191 74472-50-7 4CL, PP, 2M 
2,3,3',4,5,5',6-Heptachlorobiphenyl 192 74472-51-8 4CL, 2M 
2,3,3',4',5,5',6-Heptachlorobiphenyl 193 69782-91-8 4CL, 2M 
2,2',3,3',4,4',5,5'-Octachlorobiphenyl 194 35694-08-7 4CL, PP, 2M 
2,2',3,3',4,4',5,6-Octachlorobiphenyl 195 52663-78-2 4CL, PP, 2M 
2,2',3,3',4,4',5,6'-Octachlorobiphenyl 196 42740-50-1 4CL, PP, 2M 
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IUPAC Name 
BZ Congener 
Number 
CASRN Descriptors 
2,2',3,3',4,4',6,6'-Octachlorobiphenyl 197 33091-17-7 4CL, PP, 2M 
2,2',3,3',4,5,5',6-Octachlorobiphenyl 198 68194-17-2 4CL, 2M 
2,2',3,3',4,5,5',6'-Octachlorobiphenyl 199 52663-75-9 4CL, 2M 
2,2',3,3',4,5,6,6'-Octachlorobiphenyl 200 52663-73-7 4CL, 2M 
2,2',3,3',4,5',6,6'-Octachlorobiphenyl 201 40186-71-8 4CL, 2M 
2,2',3,3',5,5',6,6'-Octachlorobiphenyl 202 2136-99-4 4CL, 2M 
2,2',3,4,4',5,5',6-Octachlorobiphenyl 203 52663-76-0 4CL, PP, 2M 
2,2',3,4,4',5,6,6'-Octachlorobiphenyl 204 74472-52-9 4CL, PP, 2M 
2,3,3',4,4',5,5',6-Octachlorobiphenyl 205 74472-53-0 4CL, PP, 2M 
2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl 206 40186-72-9 4CL, PP, 2M 
2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl 207 52663-79-3 4CL, PP, 2M 
2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl 208 52663-77-1 4CL, 2M 
Decachlorobiphenyl 209 2051-24-3 4CL, PP, 2M 
IUPAC – International Union of Pure and Applied Chemistry 
BZ Congener Number – the congener numbering is identical to that published by K. 
Ballschmiter, R. Bacher, A. Mennel, R. Fischer, U. Riehle, and M. Swerev. Determination of 
chlorinated biphenyls, chlorinated ibenzodioxins, and chlorinated dibenzofurans by GC-MS. J. 
High Resol. Chromatogr. 15:260-270. April 1992. 
CASRN – Chemical Abstracts Service Registry Number 
CP0 / CP1 - These 68 coplanar congeners fall into one of two groups. The first group of 20 
congeners consists of those with chlorine substitution at none of the ortho positions on the 
biphenyl backbone and are referred to as CP0 or non-ortho congeners. The second group of 48 
congeners includes those with chlorine substitution at only one of the ortho positions and are 
referred to as CP1 or mono-ortho congeners. 
4CL - These 169 congeners have a total of four or more chlorine substituents, regardless of 
position. 
PP - These 54 congeners have both para positions chlorinated. 
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2M - These 140 congeners have two or more of the meta positions chlorinated. 
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